thenativeantigencompany MAB12157說明書
黃熱病病毒 NS1（克隆 HH7）特異性小鼠單克隆抗體，與其他黃病毒的 NS1 蛋白沒有交叉反應性。
SKU：MAB12157 分類：抗原和抗體,黃熱病病毒抗體
免疫熒光數據：將 Vero 細胞接種在蓋玻片上，并在 MOI 2 下用黃熱病 17D 病毒 (YF17D) 感染 24 小時。對照蓋玻片由未感染的細胞組成。用 4% PFA 固定后，樣品用抗體染色。抗體以 1:1000 的稀釋度使用，Triton X-100 用作去污劑。使用 Leica SP5 共聚焦顯微鏡（病毒學研究服務有限公司提供圖像）進行成像。
直接 ELISA：顯示 MAB12157 對黃熱病病毒 NS1 蛋白的特異性的測定。來自不同黃病毒的 NS1 抗原以 0.5ug/ml 包被在 ELISA 板上，用 0.01ug/ml 的 MAB12157 檢測，用山羊抗小鼠 IgG:HRP 觀察。
夾心 ELISA：用 MAB12157 包被的 ELISA 板用于捕獲 YFV NS1 蛋白，然后用生物s化的MAB12158進行檢測。
thenativeantigencompany2022年產品目錄
| Product Code | Product Name | Product Description |
| YFV-NS1-100 | Yellow Fever Virus NS1 Protein | Recombinant Yellow Fever Virus NS1 antigen produced in 293 human cells. Protein contains a C-terminal His-tag. |
| FLU-H5N1-NA-1000 | Influenza A [A/Thailand/1(KAN-1)/2004 (H5N1)] Neuraminidase (NA), His-tag | Recombinant Influenza A [A/Thailand/1(KAN-1)/2004 (H5N1)] Neuraminidase (NA) protein produced in HEK293 cells. |
| FLU-H5N1-NA-100 | Influenza A [A/Thailand/1(KAN-1)/2004 (H5N1)] Neuraminidase (NA), His-tag | Recombinant Influenza A [A/Thailand/1(KAN-1)/2004 (H5N1)] Neuraminidase (NA) protein produced in HEK293 cells. |
| REC31675-100 | Borrelia burgdorferi sensu stricto (B31) Surface Lipoprotein P27 | Recombinant Borrelia burgdorferi Surface Lipoprotein P27, MBP-tag. |
| REC31662-100 | Borrelia burgdorferi sensu stricto (ZS7) Flagellin Protein | Recombinant Borrelia burgdorferi Flagellin, MBP-tag. |
| REC31603-100 | Oropouche Virus Gc Protein, Mouse Fc | Recombinant Oropouche virus major glycoprotein Gc (G1) AA517-1373 of the M segment polyprotein. The transmembrane portion of the wildtype protein has been replaced with a glycine-serine linker coupled to mouse Fc. |
| REC31603-500 | Oropouche Virus Gc Protein, Mouse Fc | Recombinant Oropouche virus major glycoprotein Gc (G1) AA517-1373 of the M segment polyprotein. The transmembrane portion of the wildtype protein has been replaced with a glycine-serine linker coupled to mouse Fc. |
| REC32010-50 | SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (CHO) | Recombinant SARS-CoV-2 Spike protein S1 subunit, RBD (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H) was expressed in CHO cells. |
| REC32009-10 | SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), His-Tag (CHO) | Recombinant SARS-CoV-2 Spike protein S1 (A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H) expressed in CH |
| REC32009-20 | SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), His-Tag (CHO) | Recombinant SARS-CoV-2 Spike protein S1 (A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H) expressed in CH |
| REC32009-50 | SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), His-Tag (CHO) | Recombinant SARS-CoV-2 Spike protein S1 (A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H) expressed in CH |
| REC32010-20 | SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (CHO) | Recombinant SARS-CoV-2 Spike protein S1 subunit, RBD (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H) was expressed in CHO cells. |
| REC32010-10 | SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (CHO) | Recombinant SARS-CoV-2 Spike protein S1 subunit, RBD (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H) was expressed in CHO cells. |
| R78-TNB-2 | Clostridium Difficile Toxin B Ribotype 078 | Native toxin B purified from hypervirulent C. difficile strain 210708 ribotype 078. |
| REC31651-100 | Rubella Virus VLP (strain F-Therien) | Rubella virus VLP - produced in HEK293 cells by expression of Rubella structural polyprotein. |
| REC31651-500 | Rubella Virus VLP (strain F-Therien) | Rubella virus VLP - produced in HEK293 cells by expression of Rubella structural polyprotein. |
| HSV-gG2-100 | Herpes Simplex Virus gG2 Protein | Native HSV2 gG2 protein purified from HSV2 infected Baby Hamster Kidney (BHK) cells. |
| HSV-gG2-1000 | Herpes Simplex Virus gG2 Protein | Native HSV2 gG2 protein purified from HSV2 infected Baby Hamster Kidney (BHK) cells. |
| NAT41663-5E10-1000 | Bacteriophage MS2 (5E10 pfu/ml), 1.0 ML | MS2 phage produced in E. coli and diluted in SM buffer. The titer was determined before the freeze-down of product. Note that titer can vary up to 40% from batch to batch. |
| NAT41663-1E9-1000 | Bacteriophage MS2 (1E9 pfu/ml), 1.0 ML | MS2 phage produced in E. coli and diluted in SM buffer. The titer was determined before the freeze-down of product. Note that titer can vary up to 40% from batch to batch. |
| 5370-0020 | Escherichia coli O104:H12 Cells, Heat-Inactivated | Heat-killed Escherichia coli O104:H12 cells in dextran solution (BacTrace). |
| 5370-0021 | Escherichia coli O91 Cells, Heat-Inactivated | Heat-killed Escherichia coli O91 cells in dextran solution (BacTrace). |
| REC31672-100 | Tick-Borne Encephalitis Virus Envelope Protein, Human Fc-tag | Recombinant Tick-borne encephalitis virus (TBEV) envelope protein was C-terminally tagged using a 15 amino acid glycine-serine linker and a human IgG1 Fc-tag. |
| CHIKV-VLP-1000 | Chikungunya Virus VLP (E1 E2 C protein) | Recombinant Chikungunya Virus-Like Particles produced in 293 human cells. Chikungunya structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles |
| CHIKV-VLP-100 | Chikungunya Virus VLP (E1 E2 C protein) | Recombinant Chikungunya Virus-Like Particles produced in 293 human cells. Chikungunya structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles |
| REC31672-500 | Tick-Borne Encephalitis Virus Envelope Protein, Human Fc-tag | Recombinant Tick-borne encephalitis virus (TBEV) envelope protein was C-terminally tagged using a 15 amino acid glycine-serine linker and a human IgG1 Fc-tag. |
| REC31635-500 | Dengue Virus Serotype 1 Envelope Protein, Human Fc-Tag (HEK293) | Recombinant dengue virus serotype 1 Envelope protein (exodomain). Sequence corresponds to AA281-677 of the polyprotein. The transmembrane portion of the wildtype protein has been replaced with a glycine-serine linker coupled to human heterodimeric IgG1 Fc |
| REC31635-100 | Dengue Virus Serotype 1 Envelope Protein, Human Fc-Tag (HEK293) | Recombinant dengue virus serotype 1 Envelope protein (exodomain). Sequence corresponds to AA281-677 of the polyprotein. The transmembrane portion of the wildtype protein has been replaced with a glycine-serine linker coupled to human heterodimeric IgG1 Fc |
| CHIKV-VLP-500 | Chikungunya Virus VLP (E1 E2 C protein) | Recombinant Chikungunya Virus-Like Particles produced in 293 human cells. Chikungunya structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles |
| 5370-0023 | Borrelia Burgdorferi Cells, Heat-Inactivated | Heat-killed Borrelia burgdorferi cells in dextran solution (BacTrace). Antigen is intended for use as a positive control in immunoassays designed for Borrelia detection. |
| 5370-0011 | Campylobacter Jejuni Cells, Heat-Inactivated | Heat-killed Campylobacter jejuni cells, genus specific (BacTrace). Antigen consists of at least 4.8 x 10^8 cells/mL (1 mL of approximately 2% w/v wet packed cells) in dextran solution. |
| 5370-0005 | Legionella Pneumophila Cells, Heat-Inactivated | Heat-killed Legionaella pneumophila cells in dextran solution (BacTrace). |
| 5370-0010 | Listeria Monocytogenes Cells, Heat-Inactivated | Heat-killed Listeria monocytogenes cells, genus specific (BacTrace). Antigen consists of 1 mL of approximately 2% w/v wet packed cells in dextran solution. |
| 5370-0003 | Shigella Species Cells, Heat-Inactivated | Heat-killed Shigella boydii, Shigella flexneri, and Shigella dysenteriae cells in dextran solution (BacTrace). |
| 5370-0007 | Staphylococcus Aureus Cells, Heat-Inactivated | Heat-killed Staphylococcus aureus cells in dextran solution (BacTrace). |
| 5370-0008 | Streptococcus Pyogenes Cells, Heat-Inactivated | Heat-killed Streptococcus pyogenes (Group A) cells in dextran solution (BacTrace). |
| 5370-0009 | Streptococcus Agalactiae Cells, Heat-Inactivated | Heat-killed Streptococcus agalactiae (Group B) cells in dextran solution (BacTrace). |
| 5370-0004 | Vibrio Species Cells, Heat-Inactivated | Heat-killed Vibrio cholera non-o:1, Vibrio cholera o:1, Vibrio parahaemolyticus, Vibrio vulnificus mix (0.1 mL of approximately 2% wet packed cell w/v) in dextran solution (BacTrace). |
| 5370-0013 | Escherichia coli O157:H7 Cells, Heat-Inactivated | Heat-killed Escherichia coli serotype O157:H7 cells (1 mL of approximately 2% wet packed cell w/v) in dextran solution (BacTrace). |
| 5370-0015 | Escherichia coli O26:H11 Cells, Heat-Inactivated | Heat-killed Escherichia coli O26:H11 cells in dextran solution (BacTrace). |
| 5370-0016 | Escherichia coli O103:H8 Cells, Heat-Inactivated | Heat-killed Escherichia coli O103:H8 cells in dextran solution (BacTrace). |
| 5370-0014 | Escherichia coli O111:H8 Cells, Heat-Inactivated | Heat-killed Escherichia coli O111:H8 cells in dextran solution (BacTrace). |
| 5370-0018 | Escherichia coli O121:H19 Cells, Heat-Inactivated | Heat-killed Escherichia coli O121:H19 cells in dextran solution (BacTrace). |
| 5370-0017 | Escherichia coli O145:H2 Cells, Heat-Inactivated | Heat-killed Escherichia coli O145:H2 cells in dextran solution (BacTrace). |
| 5370-0019 | Escherichia coli O45:H2 Cells, Heat-Inactivated | Heat-killed Escherichia coli O45:H2 cells in dextran solution (BacTrace). |
| REC31964-100 | Influenza A G4 EA (H1N1) Nucleoprotein (NP), His-Tag | Recombinant influenza A swine G4 reassortant nucleoprotein. |
| REC32000-100 | Influenza A [A/Wisconsin/588/2019 (H1N1)pdm09-like virus] Hemagglutinin (HA), His-Tag | Influenza A H1N1 haemagglutinin protein expressed in HEK293 cells and purified from culture supernatant. The protein carries a C-terminal T4 foldon domain, and is predominantly presented as trimers. |
| REC32000-500 | Influenza A [A/Wisconsin/588/2019 (H1N1)pdm09-like virus] Hemagglutinin (HA), His-Tag | Influenza A H1N1 haemagglutinin protein expressed in HEK293 cells and purified from culture supernatant. The protein carries a C-terminal T4 foldon domain, and is predominantly presented as trimers. |
| REC31964-500 | Influenza A G4 EA (H1N1) Nucleoprotein (NP), His-Tag | Recombinant influenza A swine G4 reassortant nucleoprotein. |
| REC31674-100 | Borrelia burgdorferi sensu stricto (B31) ErpN/OspE Protein | Recombinant Borrelia burgdorferi ErpN/OspE, MBP-tag. |
| REC31663-100 | Borrelia burgdorferi sensu stricto (B31) OspA Protein | Recombinant Borrelia burgdorferi OspA protein produced in E. coli. |
| DENV2-ENV-100 | Dengue Virus Serotype 2 Envelope Protein (HEK293) | Recombinant Dengue Virus serotype 2 envelope protein antigen, produced in 293 human cells. The protein consists of amino acids 279-679 (polyprotein positions) with a C-terminal His6-tag, separated from the protein by a Gly6 linker. |
| REC31668-500 | Rubella Virus Nucleoprotein (strain F-Therien) | Recombinant gene product from Rubella Virus structural polyprotein. The nucleoprotein was C-terminally tagged using a 10 amino acid glycine-serine linker followed by a 6x histidine tag. The protein was produced in HEK293 cells and purified from cell lysat |
| DENV2-ENV-500 | Dengue Virus Serotype 2 Envelope Protein (HEK293) | Recombinant Dengue Virus serotype 2 envelope protein antigen, produced in 293 human cells. The protein consists of amino acids 279-679 (polyprotein positions) with a C-terminal His6-tag, separated from the protein by a Gly6 linker. |
| REC31668-100 | Rubella Virus Nucleoprotein (strain F-Therien) | Recombinant gene product from Rubella Virus structural polyprotein. The nucleoprotein was C-terminally tagged using a 10 amino acid glycine-serine linker followed by a 6x histidine tag. The protein was produced in HEK293 cells and purified from cell lysat |
| REC31643-100 | Powassan Virus NS1 Protein | Recombinant Powassan Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal 6x His-tag. The oligomerisation state is predominantly hexameric. |
| REC31643-500 | Powassan Virus NS1 Protein | Recombinant Powassan Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal 6x His-tag. The oligomerisation state is predominantly hexameric. |
| REC31999-100 | Influenza A [A/Hong Kong/1/1968 (H3N2)], Nucleoprotein (NP), His-Tag | Influenza A H3N2 nucleoprotein produced in E. coli. |
| REC31999-500 | Influenza A [A/Hong Kong/1/1968 (H3N2)], Nucleoprotein (NP), His-Tag | Influenza A H3N2 nucleoprotein produced in E. coli. |
| 5370-0012 | Helicobacter Pylori Cells, Heat-Inactivated | Heat-killed Helicobacter pylori cells in dextran solution. |
| 5370-0022 | Renibacterium Salmoninarum Cells, Heat-Inactivated | Heat-killed Renibacterium salmoninarum cells in dextran solution. |
| DENV4-ENV-500 | Dengue Virus Serotype 4 Envelope Protein (HEK293) | Recombinant Dengue Virus serotype 4 envelope protein antigen, produced in 293 human cells. The protein consists of amino acids 280-678 (polyprotein positions) with a C-terminal His6-tag, separated from the protein by a Gly6 linker. |
| 5370-0006 | Yersinia Enterocolitica Cells, Heat-Inactivated | Heat-killed Yersinia enterocolitica cells in dextran solution. |
| 5370-0002 | Salmonella Typhimurium Cells, Heat-Inactivated | Heat-killed Salmonella typhimurium cells in dextran solution. |
| DENV4-ENV-100 | Dengue Virus Serotype 4 Envelope Protein (HEK293) | Recombinant Dengue Virus serotype 4 envelope protein antigen, produced in 293 human cells. The protein consists of amino acids 280-678 (polyprotein positions) with a C-terminal His6-tag, separated from the protein by a Gly6 linker. |
| PT-TNL-500 | Bordetella Pertussis Toxin | Purified native pertussis toxin from Bordetella pertussis, lyophilised for ease of storage, CHO cluster assay tested. |
| NAT41569-100 | Dengue Virus Lysate, Serotype 2 | Dengue virus Serotype 2 is propagated in the Vero cell line. Following culture, the virus is purified by sucrose density gradient ultracentrifugation. Purified virions were lysed in 0.6M KCl containing 0.5% Triton X-100, and then subjected to heat inacti |
| REC31993-500 | Avian Influenza A [HPAI (H5N8)] Neuraminidase (NA), His-Tag | Recombinant highly pathogenic avian influenza (HPAI) neuraminidase (NA) protein purified from culture supernatant of transfected cells. |
| REC31993-100 | Avian Influenza A [HPAI (H5N8)] Neuraminidase (NA), His-Tag | Recombinant highly pathogenic avian influenza (HPAI) neuraminidase (NA) protein purified from culture supernatant of transfected cells. |
| REC31626-500 | O'nyong'nyong Virus VLP | Recombinant O’nyong’nyong virus-like particles produced in 293 human cells. O’nyong’nyong structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant parti |
| REC31626-100 | O'nyong'nyong Virus VLP | Recombinant O’nyong’nyong virus-like particles produced in 293 human cells. O’nyong’nyong structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant parti |
| REC31991-100 | Avian Influenza A [HPAI (H5N8)] Hemagglutinin (HA), His-Tag | Recombinant highly pathogenic avian influenza (HPAI) H5N8 hemagglutinin protein. |
| REC31991-500 | Avian Influenza A [HPAI (H5N8)] Hemagglutinin (HA), His-Tag | Recombinant highly pathogenic avian influenza (HPAI) H5N8 hemagglutinin protein. |
| REC31987-500 | Norovirus GII.10 VLP | Recombinant norovirus-like particles. Particles are formed by expression of VP1 in HEK293 cells, and are purified from the cytoplasm using a proprietary series of density gradients. |
| REC31990-500 | Norovirus GIX.1 VLP | Recombinant norovirus-like particles. Particles are formed by expression of VP1 in HEK293 cells, and are purified from the cytoplasm using a proprietary series of density gradients. |
| REC31989-100 | Norovirus GII.17 VLP | Recombinant norovirus-like particles. Particles are formed by expression of VP1 in HEK293 cells, and are purified from the cytoplasm using a proprietary series of density gradients. |
| REC31980-100 | Norovirus GI.3 VLP | Recombinant norovirus-like particles. Particles are formed by expression of VP1 in HEK293 cells, and are purified from the cytoplasm using a proprietary series of density gradients. |
| REC31990-100 | Norovirus GIX.1 VLP | Recombinant norovirus-like particles. Particles are formed by expression of VP1 in HEK293 cells, and are purified from the cytoplasm using a proprietary series of density gradients. |
| REC31980-500 | Norovirus GI.3 VLP | Recombinant norovirus-like particles. Particles are formed by expression of VP1 in HEK293 cells, and are purified from the cytoplasm using a proprietary series of density gradients. |
| REC31983-100 | Norovirus GII.2 VLP | Recombinant norovirus-like particles. Particles are formed by expression of VP1 in HEK293 cells, and are purified from the cytoplasm using a proprietary series of density gradients. |
| REC31987-100 | Norovirus GII.10 VLP | Recombinant norovirus-like particles. Particles are formed by expression of VP1 in HEK293 cells, and are purified from the cytoplasm using a proprietary series of density gradients. |
| REC31978-100 | Human Ferritin Light Chain Protein, Recombinant (HEK293) | Recombinant human ferritin light chain expressed in HEK293 cells. The protein forms a high-molecular weight homooligomer. |
| REC31978-1000 | Human Ferritin Light Chain Protein, Recombinant (HEK293) | Recombinant human ferritin light chain expressed in HEK293 cells. The protein forms a high-molecular weight homooligomer. |
| REC31978-500 | Human Ferritin Light Chain Protein, Recombinant (HEK293) | Recombinant human ferritin light chain expressed in HEK293 cells. The protein forms a high-molecular weight homooligomer. |
| CDA-TNL-500 | Clostridium Difficile Toxin A | Native toxin A purified from C. difficile. |
| CDA-TNL-50 | Clostridium Difficile Toxin A | Native toxin A purified from C. difficile. |
| CDA-TNL-100 | Clostridium Difficile Toxin A | Native toxin A purified from C. difficile. |
| REC31649-500 | Human MXRA8, Mouse Fc-Tag | Recombinant human MXRA8 protein, exodomain. Protein contains a C-terminal 9 amino acid glycine-serine linker followed by a mouse IgG2a Fc-tag. The Fc-tag has an apparent molecular weight of ~25kDa. |
| REC31649-100 | Human MXRA8, Mouse Fc-Tag | Recombinant human MXRA8 protein, exodomain. Protein contains a C-terminal 9 amino acid glycine-serine linker followed by a mouse IgG2a Fc-tag. The Fc-tag has an apparent molecular weight of ~25kDa. |
| REC31976-500 | SARS-CoV-2 (C.37) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) | SARS-CoV-2 Spike protein containing following amino acid changes: G75V, T76I, 246-252del, D253N, L452Q, F490S, D614G, Q675H, T859N. The protein is stabilized as a pre-fusion trimer due to six amino acid changes in the S2 portion of Spike (HexaPro). The fu |
| REC31976-100 | SARS-CoV-2 (C.37) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) | SARS-CoV-2 Spike protein containing following amino acid changes: G75V, T76I, 246-252del, D253N, L452Q, F490S, D614G, Q675H, T859N. The protein is stabilized as a pre-fusion trimer due to six amino acid changes in the S2 portion of Spike (HexaPro). The fu |
| DENV1-NS1-100 | Dengue Virus Serotype 1 NS1 Protein (HEK293) | Recombinant Dengue Virus serotype 1 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
| DENV3-NS1-100 | Dengue Virus Serotype 3 NS1 Protein (HEK293) | Recombinant Dengue Virus serotype 3 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
| DENV4-NS1-E-100 | Dengue Virus Serotype 4 NS1 Protein (HEK293) | Recombinant Dengue Virus serotype 4 NS1 protein hexamer produced in 293 human cells. Presented in EPPS-NaCl buffer to facilitate conjugation experiments. |
| REC31974-100 | SARS-CoV-2 (B.1.617.2; L452R, T478K) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | SARS-CoV-2 receptor binding domain with the two amino acid changes L452R and T478K relative to Wuhan-Hu-1 full length Spike protein. |
| DENV1-NS1-500 | Dengue Virus Serotype 1 NS1 Protein (HEK293) | Recombinant Dengue Virus serotype 1 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
| DENV4-NS1-500 | Dengue Virus Serotype 4 NS1 Protein (HEK293) | Recombinant Dengue Virus serotype 4 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
| DENV4-NS1-100 | Dengue Virus Serotype 4 NS1 Protein (HEK293) | Recombinant Dengue Virus serotype 4 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
| REC31974-500 | SARS-CoV-2 (B.1.617.2; L452R, T478K) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | SARS-CoV-2 receptor binding domain with the two amino acid changes L452R and T478K relative to Wuhan-Hu-1 full length Spike protein. |
| DENV3-NS1-500 | Dengue Virus Serotype 3 NS1 Protein (HEK293) | Recombinant Dengue Virus serotype 3 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
| DENV4-NS1-E-500 | Dengue Virus Serotype 4 NS1 Protein (HEK293) | Recombinant Dengue Virus serotype 4 NS1 protein hexamer produced in 293 human cells. Presented in EPPS-NaCl buffer to facilitate conjugation experiments. |
| DENV2-VLP-100 | Dengue Virus Serotype 2 VLP | Recombinant Dengue Virus serotype 2 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese |
| DENV2-VLP-500 | Dengue Virus Serotype 2 VLP | Recombinant Dengue Virus serotype 2 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese |
| FLU-H1N1-HA-100 | Influenza A [A/Puerto Rico/8/1934 (H1N1)] Hemagglutinin (HA), His-tag | Recombinant influenza virus H1N1 haemagglutinin exodomain protein fragment produced in 293 human cells. The C-terminally located transmembrane domain was replaced with an 8 amino acid glycine-serine linker and 6x His-tag. |
| FLU-H1N1-HA-1000 | Influenza A [A/Puerto Rico/8/1934 (H1N1)] Hemagglutinin (HA), His-tag | Recombinant influenza virus H1N1 haemagglutinin exodomain protein fragment produced in 293 human cells. The C-terminally located transmembrane domain was replaced with an 8 amino acid glycine-serine linker and 6x His-tag. |
| FLU-H1N1-HA-500 | Influenza A [A/Puerto Rico/8/1934 (H1N1)] Hemagglutinin (HA), His-tag | Recombinant influenza virus H1N1 haemagglutinin exodomain protein fragment produced in 293 human cells. The C-terminally located transmembrane domain was replaced with an 8 amino acid glycine-serine linker and 6x His-tag. |
| BP-FHA-200 | Bordetella pertussis Filamentous Hemagglutinin (FHA) | Purified FHA from B. pertussis. This product is present as 95% in its original 220 kDa form, with 5% in the reported breakdown products of 140 kDa and 90 kDa. |
| BP-FHA-50 | Bordetella pertussis Filamentous Hemagglutinin (FHA) | Purified FHA from B. pertussis. This product is present as 95% in its original 220 kDa form, with 5% in the reported breakdown products of 140 kDa and 90 kDa. |
| BP-FHA-100 | Bordetella pertussis Filamentous Hemagglutinin (FHA) | Purified FHA from B. pertussis. This product is present as 95% in its original 220 kDa form, with 5% in the reported breakdown products of 140 kDa and 90 kDa. |
| BP-FHA-1000 | Bordetella pertussis Filamentous Hemagglutinin (FHA) | Purified FHA from B. pertussis. This product is present as 95% in its original 220 kDa form, with 5% in the reported breakdown products of 140 kDa and 90 kDa. |
| REC31680-100 | Dengue Virus Serotype 2 Envelope Protein (Insect Cells) | Recombinant Dengue virus Serotype 2 Envelope protein produced in insect cells (Baculovirus). |
| REC31680-500 | Dengue Virus Serotype 2 Envelope Protein (Insect Cells) | Recombinant Dengue virus Serotype 2 Envelope protein produced in insect cells (Baculovirus). |
| REC31973-50 | Human Immunodeficiency Virus Full-Length Gag Protein [HIV-1/Clade B] | Recombinant full-length HIV-I Gag protein. |
| REC31669-100 | Borrelia burgdorferi sensu stricto (B31) VlsE Protein | Recombinant Borrelia burgdorferi VlsE, MBP-tag. |
| NAT41660-500 | Giardia Lamblia Cysts | Giardia lamblia cysts were purified from the faeces of experimentally infected gerbils using density gradient centrifugation and repeated washing. |
| NAT41660-100 | Giardia Lamblia Cysts | Giardia lamblia cysts were purified from the faeces of experimentally infected gerbils using density gradient centrifugation and repeated washing. |
| REC31971-NTRL-150 | SARS-CoV-2 RBD Protein (NTRL-IN-RBD-10) | SARS-CoV-2 B.1.617.1 (Kerala variant) receptor binding domain (E484Q, L452R amino acid changes relative to Wuhan-Hu-1). |
| REC31971-100 | SARS-CoV-2 (B.1.617.1: E484Q, L452R) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | SARS-CoV-2 B.1.617.1 (Kerala variant) receptor binding domain (E484Q, L452R amino acid changes relative to Wuhan-Hu-1). |
| REC31971-500 | SARS-CoV-2 (B.1.617.1: E484Q, L452R) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | SARS-CoV-2 B.1.617.1 (Kerala variant) receptor binding domain (E484Q, L452R amino acid changes relative to Wuhan-Hu-1). |
| REC31961-NTRL-150 | SARS-CoV-2 RBD Protein (NTRL-BZ-RBD-10) | SARS-CoV-2 Spike protein receptor binding domain of the Brazilian variant of concern. Relative to Wuhan-Hu-1 contains following amino acid changes: K417T, E484K, N501Y. |
| REC31946-NTRL-150 | SARS-CoV-2 RBD Protein (NTRL-UK-RBD-10) | SARS-CoV-2 Spike S1 RBD produced in HEK293 cells, carrying the N501Y amino acid change. |
| REC31945-NTRL-150 | SARS-CoV-2 RBD Protein (NTRL-SA-RBD-10) | SARS-CoV-2 Spike receptor binding domain RBD. Contains amino acid changes K417N, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. |
| REC31858-100 | Human Coronavirus NL63 Nucleoprotein, His-Tag (E. coli) | Recombinant human coronavirus NL63 nucleoprotein expressed in Escherichia coli. The protein was purified by immobilised metal affinity chromatography and dialysis. |
| NAT41659-500 | Cryptosporidium Parvum Oocyst Lysate | Cryptosporidium parvum oocysts were purified from the faeces of experimentally infected calves using density gradient centrifugation and repeated washing. |
| NAT41659-100 | Cryptosporidium Parvum Oocyst Lysate | Cryptosporidium parvum oocysts were purified from the faeces of experimentally infected calves using density gradient centrifugation and repeated washing. |
| REC31858-500 | Human Coronavirus NL63 Nucleoprotein, His-Tag (E. coli) | Recombinant human coronavirus NL63 nucleoprotein expressed in Escherichia coli. The protein was purified by immobilised metal affinity chromatography and dialysis. |
| REC31632-500 | Nipah Virus Glycoprotein F, Mouse Fc-Tag | Recombinant Nipah virus glycoprotein F expressed in mammalian HEK293 cells. Product has a C-terminal mouse Fc-tag. |
| REC31688-500 | Japanese Encephalitis Virus Envelope Protein | Recombinant JEV Envelope protein produced in HEK293 cells and purified from culture supernatant. Protein contains a C-terminal His-tag. |
| REC31632-100 | Nipah Virus Glycoprotein F, Mouse Fc-Tag | Recombinant Nipah virus glycoprotein F expressed in mammalian HEK293 cells. Product has a C-terminal mouse Fc-tag. |
| REC31688-100 | Japanese Encephalitis Virus Envelope Protein | Recombinant JEV Envelope protein produced in HEK293 cells and purified from culture supernatant. Protein contains a C-terminal His-tag. |
| REC31970-500 | Human Metapneumovirus (hMPV) B Fusion Glycoprotein F0, His-Tag (HEK293) | Recombinant Human Metapneumovirus (hMPV) B Glycoprotein F0, manufactured in HEK293 cells. |
| REC31970-100 | Human Metapneumovirus (hMPV) B Fusion Glycoprotein F0, His-Tag (HEK293) | Recombinant Human Metapneumovirus (hMPV) B Glycoprotein F0, manufactured in HEK293 cells. |
| REC31631-100 | Nipah Virus Glycoprotein G Recombinant Protein, Mouse Fc-Tag | Recombinant Nipah virus Nipah virus glycoprotein G (gG) exodomain, expressed in mammalian HEK293 cells. |
| REC31968-DUO-100 | SARS-CoV-2 Spike Glycoproteins (S2), Sheep Fc-Tag (HEK293/CHO Cell Duo Pack) | Pack contains recombinant SARS-CoV-2 Spike S2 proteins manufactured in both HERK293 and CHO cells. |
| REC31969-500 | Ross River Virus Recombinant Antigen | Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. |
| REC31969-100 | Ross River Virus Recombinant Antigen | Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. |
| REC31655-100 | Rubella Spike Glycoprotein E1 (strain F-Therien) | Recombinant Rubella virus glycoprotein E1, produced in HEK293 cells by transient transfection. A 16 amino acid glycine-serine linker followed by a sheep IgG Fc region (CH2-CH3) was added to the C-terminus of the protein. |
| REC31967-DUO-500 | SARS-CoV-2 Spike Glycoproteins (S1), Sheep Fc-Tag (HEK293/CHO Cell Duo Pack) | Pack contains recombinant SARS-CoV-2 Spike S1 proteins manufactured in both HERK293 and CHO cells. |
| REC31671-100 | Tick-Borne Encephalitis Virus Envelope Protein, Mouse Fc-tag | Recombinant gene product from Tick-borne encephalitis virus (TBEV) polyprotein. The envelope protein was C-terminally tagged using a 15 amino acid glycine-serine linker and a mouse Fc-tag. The Fc-tag has an approximate molecular weight of 25kDa. |
| REC31967-DUO-100 | SARS-CoV-2 Spike Glycoproteins (S1), Sheep Fc-Tag (HEK293/CHO Cell Duo Pack) | Pack contains recombinant SARS-CoV-2 Spike S1 proteins manufactured in both HERK293 and CHO cells. |
| REC31655-500 | Rubella Spike Glycoprotein E1 (strain F-Therien) | Recombinant Rubella virus glycoprotein E1, produced in HEK293 cells by transient transfection. A 16 amino acid glycine-serine linker followed by a sheep IgG Fc region (CH2-CH3) was added to the C-terminus of the protein. |
| CDB-TDL-500 | Clostridium Difficile Toxoid B | Native toxin B purified from C. difficile strain VPI10463 (toxinotype 0), converted to inactive toxoid form |
| CDB-TDL-50 | Clostridium Difficile Toxoid B | Native toxin B purified from C. difficile strain VPI10463 (toxinotype 0), converted to inactive toxoid form |
| CDB-TDL-100 | Clostridium Difficile Toxoid B | Native toxin B purified from C. difficile strain VPI10463 (toxinotype 0), converted to inactive toxoid form |
| REC31631-500 | Nipah Virus Glycoprotein G Recombinant Protein (Mouse Fc) | Recombinant Nipah virus Nipah virus glycoprotein G (gG) exodomain, expressed in mammalian HEK293 cells. |
| REC31968-DUO-500 | SARS-CoV-2 Spike Glycoproteins (S2), Sheep Fc-Tag (HEK293/CHO Cell Duo Pack) | Pack contains recombinant SARS-CoV-2 Spike S2 proteins manufactured in both HERK293 and CHO cells. |
| REC31966-100 | SARS-CoV-2 Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293) | Recombinant SARS-CoV-2 pre-fusion stabilized Spike protein of the Wuhan-Hu-1 amino acid sequence. The protein has been stabilized using six proline amino acid changes located in S2 (HexaPro) and the T4 foldon domain. The furin cleavage site has been repla |
| REC31966-500 | SARS-CoV-2 Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293) | Recombinant SARS-CoV-2 pre-fusion stabilized Spike protein of the Wuhan-Hu-1 amino acid sequence. The protein has been stabilized using six proline amino acid changes located in S2 (HexaPro) and the T4 foldon domain. The furin cleavage site has been repla |
| DENV3-VLP-100 | Dengue Virus Serotype 3 VLP | Recombinant Dengue Virus serotype 3 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese |
| DENV3-VLP-500 | Dengue Virus Serotype 3 VLP | Recombinant Dengue Virus serotype 3 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese |
| REC31613-500 | Cytomegalovirus Glycoprotein B (gB), Human Fc | Recombinant gene product from HCMV UL55 locus, amino acid 1-700. A glycine-serine linker and human IgG1 Fc-tag was fused to amino acid 700 of gB. Amino acids 457-460 were replaced with the sequence TTQT to prevent furin cleavage of gB. |
| REC31613-100 | Cytomegalovirus Glycoprotein B (gB), Human Fc | Recombinant gene product from HCMV UL55 locus, amino acid 1-700. A glycine-serine linker and human IgG1 Fc-tag was fused to amino acid 700 of gB. Amino acids 457-460 were replaced with the sequence TTQT to prevent furin cleavage of gB. |
| VC-CTXB-50 | Cholera Toxin Subunit B | Vibrio cholerae serotype O1 CTXB Protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| ZIKVSU-NS1-100 | Zika Virus NS1 Protein (Suriname Strain) | Recombinant Zika Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. The oligomerisation state is predominantly hexameric. |
| ZIKVSU-NS1-1000 | Zika Virus NS1 Protein (Suriname Strain) | Recombinant Zika Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. The oligomerisation state is predominantly hexameric. |
| VC-CTXB-1000 | Cholera Toxin Subunit B | Vibrio cholerae serotype O1 CTXB Protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| REC31962-100 | Human Metapneumovirus (hMPV) A Glycoprotein G, His-Tag (HEK293) | Human metapneumovirus glycoprotein G ectodomain. The protein was produced in HEK293 cells and purified from culture supernatant. |
| REC31961-100 | SARS-CoV-2 (B.1.1.28: K417T, E484K, N501Y) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | SARS-CoV-2 Spike protein receptor binding domain of the Brazilian variant of concern. Relative to Wuhan-Hu-1 contains following amino acid changes: K417T, E484K, N501Y. |
| REC32006 | SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | Recombinant SARS-CoV-2 (Omicron variant) Spike glycoprotein S1. Relative to Wuhan-Hu-1 the protein contains following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, |
| REC32007 | SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | Recombinant SARS-CoV-2 Omicron variant Spike receptor binding domain protein. Relative to Wuhan-Hu-1 this protein has following amino acid changes: G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H. |
| DENV2-NS1-100 | Dengue Virus Serotype 2 NS1 Protein (HEK293) | Recombinant Dengue Virus serotype 2 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
| REC31961-500 | SARS-CoV-2 (B.1.1.28: K417T, E484K, N501Y) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | SARS-CoV-2 Spike protein receptor binding domain of the Brazilian variant of concern. Relative to Wuhan-Hu-1 contains following amino acid changes: K417T, E484K, N501Y. |
| REC31963-100 | SARS-CoV-2 (B.1.351) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) | SARS-CoV-2 Spike protein, South African variant of concern. Relative to Wuhan-Hu-1 contains following amino acid changes: L18F, D80A, D215G, del242-244, K417N, E484K, N501Y, D614G, A701V. The protein contains six proline amino acid changes (commonly know |
| DENV2-NS1-500 | Dengue Virus Serotype 2 NS1 Protein (HEK293) | Recombinant Dengue Virus serotype 2 NS1 protein produced in 293 human cells. The oligomerisation state is predominantly hexameric. |
| REC31962-500 | Human Metapneumovirus (hMPV) A Glycoprotein G, His-Tag (HEK293) | Human metapneumovirus glycoprotein G ectodomain. The protein was produced in HEK293 cells and purified from culture supernatant. |
| REC31963-500 | SARS-CoV-2 (B.1.351) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293) | SARS-CoV-2 Spike protein, South African variant of concern. Relative to Wuhan-Hu-1 contains following amino acid changes: L18F, D80A, D215G, del242-244, K417N, E484K, N501Y, D614G, A701V. The protein contains six proline amino acid changes (commonly know |
| MP901-1000 | Mycoplasma Pneumoniae Antigen | Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
| R27-TNB-10 | Clostridium Difficile Toxin B, Ribotype 027 | Native toxin B purified from hypervirulent C. difficile strain R20291 (Stoke Mandeville) ribotype 027. |
| R27-TNB-2 | Clostridium Difficile Toxin B Ribotype 027 | Native toxin B purified from hypervirulent C. difficile strain R20291 (Stoke Mandeville) ribotype 027. |
| MP901-200 | Mycoplasma Pneumoniae Antigen | Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
| CHIKV-E1-500 | Chikungunya Virus E1 Envelope Protein (HEK293) | Recombinant Chikungunya virus envelope protein 1 (E1), expressed in HEK293 mammalian cells. |
| CHIKV-E1-100 | Chikungunya Virus E1 Envelope Protein (HEK293) | Recombinant Chikungunya virus envelope protein 1 (E1), expressed in HEK293 mammalian cells. |
| REC31876-NTRL-10.5 | HRP-Labelled ACE2 Protein (NTRL-RBD-10) | Human ACE2 was produced in HEK293 cells by transient transfection. The protein was C-terminally truncated to remove both the ADAM17 and TMPRSS2 cleavage sites. The protein was then purified from culture supernatant by Protein G chromatography |
| REC31637-500 | Nipah Virus Glycoprotein G, Human Fc-Tag (HEK293) | Recombinant Nipah virus glycoprotein G (gG) exodomain, expressed in mammalian HEK293 cells. |
| REC31637-100 | Nipah Virus Glycoprotein G Recombinant Protein (Human Fc) | Recombinant Nipah virus glycoprotein G (gG) exodomain, expressed in mammalian HEK293 cells. |
| REC31921-500 | Human T-Cell Lymphotropic Virus Type 2 (HTLV-2) Envelope Protein, Sheep Fc-Tag (HEK293) | Human T-cell Leukemia Virus 2 (HTLV-2) Envelope Protein produced in HEK293 cells with a TEV cleavable C-terminal sheep Fc-tag. The protein was purified from culture supernatant by Protein A chromatography and Hydrophobic Interaction Chromatography. The fu |
| REC31921-100 | Human T-Cell Lymphotropic Virus Type 2 (HTLV-2) Envelope Protein, Sheep Fc-Tag (HEK293) | Human T-cell Leukemia Virus 2 (HTLV-2) Envelope Protein produced in HEK293 cells with a TEV cleavable C-terminal sheep Fc-tag. The protein was purified from culture supernatant by Protein A chromatography and Hydrophobic Interaction Chromatography. The fu |
| REC31958-20 | Streptolysin O (Hemolytic Streptococcus), Active | Recombinant streptolysin O, highly purified from E. coli over-expressing SLO of Group C hemolytic Streptococci (6xHis-tagged to the signal peptide removed N-terminal of SLO). Functional in membrane pore formation to introduce molecules into living animal |
| REC31956-50 | Bordetella Pertussis Adenylate Cyclase, Active | This product is a recombinant Bordetella pertussis toxin expressed in E. coli from the structural gene cyaA and its activator gene cyaC and purified by the method of Friedman. Friedman RL (1987) Bordetella pertussis adenylate cyclase: isolation and purifi |
| REC31957-50 | Pasteurella Multocida Toxin, Active | This product is derived from a recombinant ToxA with N-terminal 6xHis-tag expressed in E. coli. |
| REC31951-500 | Influenza A [A/Cambodia/e0826360/2020 (H3N2)-like virus] Hemagglutinin (HA), His-Tag | Influenza A H3N2 hemagglutinin protein expressed in HEK293 cells and purified from culture supernatant. The protein carries a C-terminal T4 foldon domain, and is predominantly presented as trimers. |
| REC31953-100 | Influenza B [B/Washington/02/2019 (B/Victoria lineage)-like virus] Hemagglutinin (HA), His-tag | Recombinant influenza hemagglutinin protein produced in HEK293 cells and purified from supernatant. The protein carries a C-terminal T4 foldon domain, and is predominantly presented as trimers. |
| REC31955-500 | Influenza B [B/Phuket/3073/2013 (B/Yamagata lineage)-like virus] Neuraminidase (NA), His-tag | Recombinant influenza B neuraminidase protein produced in HEK293 cells and purified from culture supernatant. |
| REC31953-500 | Influenza B [B/Washington/02/2019 (B/Victoria lineage)-like virus] Hemagglutinin (HA), His-tag | Recombinant influenza hemagglutinin protein produced in HEK293 cells and purified from supernatant. The protein carries a C-terminal T4 foldon domain, and is predominantly presented as trimers. |
| REC31954-100 | Influenza B [B/Phuket/3073/2013 (B/Yamagata lineage)-like virus] Hemagglutinin (HA), His-Tag | Recombinant influenza B hemagglutinin protein produced in HEK293 cells and purified from culture supernatant. The protein carries a C-terminal T4 foldon domain, and is predominantly presented as trimers. |
| REC31954-500 | Influenza B [B/Phuket/3073/2013 (B/Yamagata lineage)-like virus] Hemagglutinin (HA), His-Tag | Recombinant influenza B Hemagglutinin protein produced in HEK293 cells and purified from culture supernatant. The protein carries a C-terminal T4 foldon domain, and is predominantly presented as trimers. |
| REC31951-100 | Influenza A [A/Cambodia/e0826360/2020 (H3N2)-like virus] Hemagglutinin (HA), His-Tag | Influenza A H3N2 hemagglutinin protein expressed in HEK293 cells and purified from culture supernatant. The protein carries a C-terminal T4 foldon domain, and is predominantly presented as trimers. |
| REC31950-100 | Influenza A [A/Victoria/2570/2019 (H1N1)pdm09-like virus] Neuraminidase (NA), His-tag | Influenza A H1N1 neuraminidase protein expressed in HEK293 cells and purified from culture supernatant. |
| REC31952-100 | Influenza A [A/Cambodia/e0826360/2020 (H3N2)-like virus] Neuraminidase (NA), His-tag | Recombinant influenza A H3N2 neuraminidase protein produced in HEK293 cells and purified from culture supernatant. |
| REC31949-500 | Influenza A [A/Victoria/2570/2019 (H1N1)pdm09-like virus] Hemagglutinin (HA), His-Tag | Influenza A H1N1 haemagglutinin protein expressed in HEK293 cells and purified from cultrue supernatant. The protein carries a C-terminal T4 foldon domain, and is predominantly presented as trimers. |
| REC31949-100 | Influenza A [A/Victoria/2570/2019 (H1N1)pdm09-like virus] Hemagglutinin (HA), His-Tag | Influenza A H1N1 haemagglutinin protein expressed in HEK293 cells and purified from culture supernatant. The protein carries a C-terminal T4 foldon domain, and is predominantly presented as trimers. |
| REC31950-500 | Influenza A [A/Victoria/2570/2019 (H1N1)pdm09-like virus] Neuraminidase (NA), His-tag | Influenza A H1N1 neuraminidase protein expressed in HEK293 cells and purified from culture supernatant. |
| REC31952-500 | Influenza A [A/Cambodia/e0826360/2020 (H3N2)-like virus] Neuraminidase (NA), His-tag | Recombinant influenza A H3N2 neuraminidase protein produced in HEK293 cells and purified from culture supernatant. |
| REC31955-100 | Influenza B [B/Phuket/3073/2013 (B/Yamagata lineage)-like virus] Neuraminidase (NA), His-tag | Recombinant influenza B neuraminidase protein produced in HEK293 cells and purified from culture supernatant. |
| CDA-TDL-50 | Clostridium Difficile Toxoid A | Native toxin A purified from C. difficile strain VPI10463 (toxinotype 0), converted to inactive toxoid form. |
| REC31920-500 | Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) Envelope Protein, Sheep Fc-Tag (HEK293) | Recombinant human T-cell lymphotropic virus type 1 (HTLV-1) envelope protein. The protein was produced in HEK293 cells and purified from culture supernatant with a TEV cleavage site and C-terminal sheep Fc-tag. |
| REC31920-100 | Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) Envelope Protein, Sheep Fc-Tag (HEK293) | Recombinant human T-cell lymphotropic virus type 1 (HTLV-1) envelope protein. The protein was produced in HEK293 cells and purified from culture supernatant with a TEV cleavage site and C-terminal sheep Fc-tag. |
| CDA-TDL-500 | Clostridium Difficile Toxoid A | Native toxin A purified from C. difficile strain VPI10463 (toxinotype 0), converted to inactive toxoid form. |
| CDA-TDL-100 | Clostridium Difficile Toxoid A | Native toxin A purified from C. difficile strain VPI10463 (toxinotype 0), converted to inactive toxoid form. |
| REC31627-500 | Yellow Fever Virus Envelope Protein, Human Heterodimeric Fc-Tag | Recombinant Yellow Fever virus Envelope protein. Sequence corresponds to AA287-678 of the polyprotein. The transmembrane portion of the wildtype protein has been replaced with a glycine-serine linker coupled to a human IgG1 Fc region that carries mutation |
| REC31627-100 | Yellow Fever Virus Envelope Protein, Human Heterodimeric Fc-Tag | Recombinant Yellow Fever virus Envelope protein. Sequence corresponds to AA287-678 of the polyprotein. The transmembrane portion of the wildtype protein has been replaced with a glycine-serine linker coupled to a human IgG1 Fc region that carries mutation |
| REC31933-500 | SARS-CoV-2 (N439K Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | Recombinant SARS-CoV-2 spike subunit 1 protein containing N439K mutation. |
| REC31933-100 | SARS-CoV-2 (N439K Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | Recombinant SARS-CoV-2 spike subunit 1 protein containing N439K mutation. |
| TBEV-NS1-500 | Tick-Borne Encephalitis Virus NS1 Protein | Recombinant Tick-Borne Encephalitis Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| USUV-NS1-500 | Usutu Virus NS1 Protein | Recombinant Usutu Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| WNV-NS1 | West Nile Virus NS1 Protein | Recombinant West Nile Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| WNV-NS1-500 | West Nile Virus NS1 Protein | Recombinant West Nile Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| USUV-NS1 | Usutu Virus NS1 Protein | Recombinant Usutu Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| A40P-1000 | Adenovirus Type 40 Antigen | Concentrated and purified Adenovirus type 40 virions from a caesium chloride density gradient banding of an optimally-infected 293-cell lysate. |
| REC31948-100 | Human Metapneumovirus (hMPV) B Glycoprotein G, His-Tag (HEK293) | Human metapneumovirus B glycoprotein G (attachment protein) produced in HEK293 cells and purified from culture supernatant. |
| REC31948-500 | Human Metapneumovirus (hMPV) B Glycoprotein G, His-Tag (HEK293) | Human metapneumovirus B glycoprotein G (attachment protein) produced in HEK293 cells and purified from culture supernatant. |
| REC31945-100 | SARS-CoV-2 (501Y.V2: K417N, E484K, N501Y) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | SARS-CoV-2 Spike receptor binding domain RBD. Contains amino acid changes K417N, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. |
| REC31945-500 | SARS-CoV-2 (501Y.V2: K417N, E484K, N501Y) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | SARS-CoV-2 Spike receptor binding domain RBD. Contains amino acid changes K417N, E484K, N501Y relative to Wuhan Hu-1. The protein was produced in HEK293 cells and purified from culture supernatant. |
| REC31946-100 | SARS-CoV-2 (N501Y Mutant) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | SARS-CoV-2 Spike S1 RBD (AA1-223), carrying the N501Y amino acid change. This change is present in all three major global SARS-CoV-2 variants: B.1.1.7, B.1.1.28 and B.1.351. The protein was produced in HEK293 cells and purified from culture supernanant. |
| REC31946-500 | SARS-CoV-2 (N501Y Mutant) Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | SARS-CoV-2 Spike S1 RBD (AA1-223), carrying the N501Y amino acid change. This change is present in all three major global SARS-CoV-2 variants: B.1.1.7, B.1.1.28 and B.1.351. The protein was produced in HEK293 cells and purified from culture supernanant. |
| REC31944-500 | SARS-CoV-2 (B.1.1.28) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293) | Pre-fusion stabilized SARS-CoV-2 Spike protein of the virus variant B.1.1.28 (P1, Brazilian variant) containing amino acid changes L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F relative to Wuhan Hu-1. The protein was pr |
| REC31944-100 | SARS-CoV-2 (B.1.1.28) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293) | Pre-fusion stabilized SARS-CoV-2 Spike protein of the virus variant B.1.1.28 (P1, Brazilian variant) containing amino acid changes L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F relative to Wuhan Hu-1. The protein was pr |
| REC31930-100 | SARS-CoV-2 (D614G, N501Y Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing both D614G and N501Y amino acid changes relative to the Wuhan-Hu-1 isolate. The N501Y mutation has been reported to increase binding affinity to human ACE2. |
| REC31930-500 | SARS-CoV-2 (D614G, N501Y Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing both D614G and N501Y amino acid changes relative to the Wuhan-Hu-1 isolate. The N501Y mutation has been reported to increase binding affinity to human ACE2. |
| REC31923-500 | SARS-CoV-2 (B.1.1.7) Spike Glycoprotein (Full-Length), His-Tag (HEK293) | SARS-CoV-2 Spike protein that contains all amino acid changes of the “UK variant" B.1.1.7 of SARS-CoV-2: 69-70del, Y144del, N501Y, A570D, P681H, T716I, S982A, D1118H relative to Wuhan-Hu-1. This construct has a functional furin cleavage site. |
| AH01-1000 | Adenovirus Type 5 Hexon Protein | Purified hexon protein. Hexon is the major Adenovirus capsid protein. It is present as 240 copies which form 20 facets of the icosahedral capsid. |
| AH01-100 | Adenovirus Type 5 Hexon Protein | Purified hexon protein. Hexon is the major Adenovirus capsid protein. It is present as 240 copies which form 20 facets of the icosahedral capsid. |
| REC31923-100 | SARS-CoV-2 (B.1.1.7) Spike Glycoprotein (Full-Length), His-Tag (HEK293) | SARS-CoV-2 Spike protein that contains all amino acid changes of the “UK variant" B.1.1.7 of SARS-CoV-2: 69-70del, Y144del, N501Y, A570D, P681H, T716I, S982A, D1118H relative to Wuhan-Hu-1. This construct has a functional furin cleavage site. |
| REC31932-500 | SARS-CoV-2 (A222V Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing A222V amino acid changes. |
| REC31932-100 | SARS-CoV-2 (A222V Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing A222V amino acid changes. |
| DENV4-VLP-100 | Dengue Virus Serotype 4 VLP | Recombinant Dengue Virus serotype 4 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese |
| DENV4-VLP-250 | Dengue Virus Serotype 4 VLP | Recombinant Dengue Virus serotype 4 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese |
| DENV4-VLP-500 | Dengue Virus Serotype 4 VLP | Recombinant Dengue Virus serotype 4 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese |
| DENV1-VLP-500 | Dengue Virus Serotype 1 VLP | Recombinant Dengue Virus serotype 1 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese |
| DENV1-VLP-250 | Dengue Virus Serotype 1 VLP | Recombinant Dengue Virus serotype 1 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese |
| DENV1-VLP-100 | Dengue Virus Serotype 1 VLP | Recombinant Dengue Virus serotype 1 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese |
| REC31924-100 | SARS-CoV-2 (B.1.1.7) Stabilized Spike Glycoprotein, His-Strep-Tag (HEK293) | SARS-CoV-2 HexaPro stabilized Spike glycoprotein containing deletions and amino acid changes in accordance with variant B.1.1.7 (“UK variant"): 69-70del, Y144del, N501Y, A570D, P681H, T716I, S982A, D1118H relative to Wuhan-Hu-1. The polybasic furin cleava |
| REC31924-500 | SARS-CoV-2 (B.1.1.7) Stabilized Spike Glycoprotein, His-Strep-Tag (HEK293) | SARS-CoV-2 HexaPro stabilized Spike glycoprotein containing deletions and amino acid changes in accordance with variant B.1.1.7 (“UK variant"): 69-70del, Y144del, N501Y, A570D, P681H, T716I, S982A, D1118H relative to Wuhan-Hu-1. The polybasic furin cleava |
| REC31926-100 | SARS-CoV-2 (501.V2) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293) | SARS-CoV-2 HexaPro stabilized Spike glycoprotein containing amino acid changes in accordance with variant 501.V2 (“South African variant"): D80A, D215G, K417N, E484K, N501Y, A701V relative to Wuhan-Hu-1. This protein has the polybasic furin cleavage site |
| REC31926-500 | SARS-CoV-2 (501.V2) Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293) | SARS-CoV-2 HexaPro stabilized Spike glycoprotein containing amino acid changes in accordance with variant 501.V2 (“South African variant"): D80A, D215G, K417N, E484K, N501Y, A701V relative to Wuhan-Hu-1. This protein has the polybasic furin cleavage site |
| PT-TNL-50 | Bordetella Pertussis Toxin | Purified native pertussis toxin from Bordetella pertussis, lyophilised for ease of storage, CHO cluster assay tested. |
| REC31940-100 | SARS-CoV-2 NSP1 Protein, His-Tag (E. coli) | SARS-CoV-2 non-structural protein 1 (NSP1) is a recombinant protein manufactured in E. coli to greater than 90% purity. |
| REC31934-100 | Marburg Virus Envelope Glycoprotein (GP), Sheep Fc-Tag (HEK293) | Recombinant Marburg virus glycoprotein produced in HEK293 cells and purified from culture supernatant. The product contains both furin cleaved and uncleaved version of the protein. |
| CMV-CL-100 | Cytomegalovirus Cell Lysate Antigen | A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle. |
| CMV-CL-1000 | Cytomegalovirus Cell Lysate Antigen | A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle. |
| REC31934-500 | Marburg Virus Envelope Glycoprotein (GP), Sheep Fc-Tag (HEK293) | Recombinant Marburg virus glycoprotein produced in HEK293 cells and purified from culture supernatant. The product contains both furin cleaved and uncleaved version of the protein. |
| CMV-HP-1000 | Cytomegalovirus Purified Antigen | A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
| CMV-HP-500 | Cytomegalovirus Purified Antigen | A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
| REC31665-100 | Borrelia burgdorferi sensu stricto (B31) OspC Protein | Recombinant Borrelia burgdorferi OspC, MBP-tag. |
| CMV-HP-100 | Cytomegalovirus Purified Antigen | A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
| CMV-PENT-100 | Cytomegalovirus gH Pentamer Complex | Recombinant human cytomegalovirus pentamer protein complex, consisting of proteins UL75 (gH), UL115 (gL), UL128, UL130 and UL131A, produced in HEK293 cells. Contains a His-tag. |
| CMV-PENT-1000 | Cytomegalovirus gH Pentamer Complex | Recombinant human cytomegalovirus pentamer protein complex, consisting of proteins UL75 (gH), UL115 (gL), UL128, UL130 and UL131A, produced in HEK293 cells. Contains a His-tag. |
| REC31939-100 | Human CD147 (BSG) Recombinant Protein, His-Tag (HEK293) | Recombinant human basigin (BSG, CD147) produced in HEK293 cells and purified from culture supernatant. There is evidence that this protein can serve as an alternative entry receptor for SARS-CoV-2. |
| CMV-PENT-50 | Cytomegalovirus gH Pentamer Complex | Recombinant human cytomegalovirus pentamer protein complex, consisting of proteins UL75 (gH), UL115 (gL), UL128, UL130 and UL131A, produced in HEK293 cells. Contains a His-tag. |
| REC31939-500 | Human CD147 (BSG) Recombinant Protein, His-Tag (HEK293) | Recombinant human basigin (BSG, CD147) produced in HEK293 cells and purified from culture supernatant. There is evidence that this protein can serve as an alternative entry receptor for SARS-CoV-2. |
| CMV-PENT-500 | Cytomegalovirus gH Pentamer Complex | Recombinant human cytomegalovirus pentamer protein complex, consisting of proteins UL75 (gH), UL115 (gL), UL128, UL130 and UL131A, produced in HEK293 cells. Contains a His-tag. |
| REC31938-50 | SARS-CoV-2 NSP10/NSP16 Methyltransferase, Active | Recombinant SARS-CoV-2 NSP10/NSP16 methyltransferase includes full length NSP10 and NSP16 expressed in E. coli using C-terminal His tag. |
| REC31935-10 | SARS-CoV-2 NSP7 Protein, His-Tag (E. coli) | Recombinant full-length viral non-structural protein 7 (NSP7) is expressed in E. coli using a C-terminal His-tag. |
| REC31936-50 | SARS-CoV-2 NSP8 Protein, His-Tag (E. coli) | Recombinant full-length viral non-structural protein 8 (NSP8) is expressed in E. coli using a C-terminal His-tag. |
| REC31938-10 | SARS-CoV-2 NSP10/NSP16 Methyltransferase, Active | Recombinant SARS-CoV-2 NSP10/NSP16 methyltransferase includes full length NSP10 and NSP16 expressed in E. coli using C-terminal His tag. |
| REC31937-10 | SARS-CoV-2 NSP14 Methyltransferase, Active | Recombinant SARS-CoV-2 non-structural protein 14 (NSP14) was expressed in E. coli using a C-terminal His tag. |
| REC31937-20 | SARS-CoV-2 NSP14 Methyltransferase, Active | Recombinant SARS-CoV-2 non-structural protein 14 (NSP14) was expressed in E. coli using a C-terminal His tag. |
| REC31937-50 | SARS-CoV-2 NSP14 Methyltransferase, Active | Recombinant SARS-CoV-2 non-structural protein 14 (NSP14) was expressed in E. coli using a C-terminal His tag. |
| REC31938-20 | SARS-CoV-2 NSP10/NSP16 Methyltransferase, Active | Recombinant SARS-CoV-2 NSP10/NSP16 methyltransferase includes full length NSP10 and NSP16 expressed in E. coli using C-terminal His tag. |
| REC31936-20 | SARS-CoV-2 NSP8 Protein, His-Tag (E. coli) | Recombinant full-length viral non-structural protein 8 (NSP8) is expressed in E. coli using a C-terminal His-tag. |
| REC31936-10 | SARS-CoV-2 NSP8 Protein, His-Tag (E. coli) | Recombinant full-length viral non-structural protein 8 (NSP8) is expressed in E. coli using a C-terminal His-tag. |
| REC31935-20 | SARS-CoV-2 NSP7 Protein, His-Tag (E. coli) | Recombinant full-length viral non-structural protein 7 (NSP7) is expressed in E. coli using a C-terminal His-tag. |
| REC31935-50 | SARS-CoV-2 NSP7 Protein, His-Tag (E. coli) | Recombinant full-length viral non-structural protein 7 (NSP7) is expressed in E. coli using a C-terminal His-tag. |
| REC31620-100 | Norovirus GII.4 VLP | Recombinant Norovirus GII.4 VP1 Virus-Like Particles produced in 293 human cells. Norovirus VP1 structural protein is transiently expressed to form a particle without the non-structural proteins or genome. Resultant particles are totally non-infectious. |
| REC31620-500 | Norovirus GII.4 VLP | Recombinant Norovirus GII.4 VP1 Virus-Like Particles produced in 293 human cells. Norovirus VP1 structural protein is transiently expressed to form a particle without the non-structural proteins or genome. Resultant particles are totally non-infectious. |
| FLUH9N2-HA-100 | Influenza A [A/Guinea fowl/Hong Kong/WF10/1999 (H9N2)] Hemagglutinin (HA), His-tag | Recombinant Influenza A [A/Guinea fowl/Hong Kong/WF10/99(H9N2)] Hemagglutinin (HA) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| FLUH9N2-HA-1000 | Influenza A [A/Guinea fowl/Hong Kong/WF10/1999 (H9N2)] Hemagglutinin (HA), His-tag | Recombinant Influenza A [A/Guinea fowl/Hong Kong/WF10/99(H9N2)] Hemagglutinin (HA) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| REC31922-100 | SARS-CoV-2 Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293) | SARS-CoV-2 Spike protein containing 6 mutations in S2 which stabilises the protein as a pre-fusion trimer. The protein was produced according to Hsieh et al., 2020 in HEK293 cells and purified from culture supernatant by affinity chromatography. |
| REC31922-500 | SARS-CoV-2 Stabilized Spike Glycoprotein (Full-Length), His-Strep-Tag (HEK293) | SARS-CoV-2 Spike protein containing 6 mutations in S2 which stabilises the protein as a pre-fusion trimer. The protein was produced according to Hsieh, Goldsmith et al., Science 2020 in HEK293 cells and purified from culture supernatant by affinity chroma |
| REC31906-100 | Nairobi Sheep Disease Virus Glycoprotein Gc, Human Fc-Tag (HEK293) | Nairobi sheep disease virus major glycoprotein Gc, produced in HEK293 cells and purified from culture supernatant by Protein G and ion chromatography. |
| REC31904-500 | Nairobi Sheep Disease Virus Glycoprotein Gn, Human Fc-Tag (HEK293) | Nairobi sheep disease virus minor glycoprotein Gn, tagged with a human IgG1 Fc-tag. The protein was purified by affinity chromatography on Protein G. |
| REC31906-500 | Nairobi Sheep Disease Virus Glycoprotein Gc, Human Fc-Tag (HEK293) | Nairobi sheep disease virus major glycoprotein Gc, produced in HEK293 cells and purified from culture supernatant by Protein G and ion chromatography. |
| REC31904-100 | Nairobi Sheep Disease Virus Glycoprotein Gn, Human Fc-Tag (HEK293) | Nairobi sheep disease virus minor glycoprotein Gn, tagged with a human IgG1 Fc-tag. The protein was purified by affinity chromatography on Protein G. |
| REC31853-500 | Salmonella Typhi Outer Membrane Protein (OMP), His-Tag (E. coli) | Typhoid outer membrane protein (OMP) recombinant protein. |
| REC31852-1000 | Salmonella Typhi Hemolysin E (HlyE) Protein, His-Tag (E. coli) | Typhoid Hemolysin E (HlyE) recombinant protein |
| REC31853-1000 | Salmonella Typhi Outer Membrane Protein (OMP), His-Tag (E. coli) | Typhoid outer membrane protein (OMP) recombinant protein. |
| REC31852-500 | Salmonella Typhi Hemolysin E (HlyE) Protein, His-Tag (E. coli) | Typhoid Hemolysin E (HlyE) recombinant protein |
| PT-TNF-1000 | Bordetella Pertussis Toxin (Frozen) | Purified pertussis toxin from B. pertussis strain NC10739/ACTC 9797 |
| PT-TNF-100 | Bordetella Pertussis Toxin (Frozen) | Purified pertussis toxin from B. pertussis strain NC10739/ACTC 9797. |
| REC31914-500 | Influenza A [A/Ohio/12/2017 (H3N2)] Neuraminidase (NA), His-tag | Influenza virus A H3N2 virus neuraminidase (NA) was expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and dialysis. |
| REC31914-100 | Influenza A [A/Ohio/12/2017 (H3N2)] Neuraminidase (NA), His-tag | Influenza virus A H3N2 virus neuraminidase (NA) was expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and dialysis. |
| REC31618-100 | Chikungunya Virus E2 Envelope Protein (HEK293), Human Fc-Tag | Recombinant gene product from Chikungunya virus, corresponding to amino acid 326-693 of the polyprotein. A glycine-serine linker and Fc-tag was fused to the C-terminus of this recombinant protein. |
| REC31618-500 | Chikungunya Virus E2 Envelope Protein (HEK293), Human Fc-Tag | Recombinant gene product from Chikungunya virus, corresponding to amino acid 326-693 of the polyprotein. A glycine-serine linker and Fc-tag was fused to the C-terminus of this recombinant protein. |
| REC31617-500 | Chikungunya Virus E2 Envelope Protein, (HEK293) Mouse Fc-Tag | Recombinant gene product from Chikungunya virus, corresponding to amino acid 326-693 of the polyprotein. A glycine-serine linker and mouse Fc-tag was fused to the C-terminus of this recombinant protein. |
| REC31617-100 | Chikungunya Virus E2 Envelope Protein, (HEK293) Mouse Fc-Tag | Recombinant gene product from Chikungunya virus, corresponding to amino acid 326-693 of the polyprotein. A glycine-serine linker and mouse Fc-tag was fused to the C-terminus of this recombinant protein. |
| REC31915-200 | Recombinant Human IgE-Fc domain | Recombinant human immunoglobulin epsilon heavy chain constant region (IgE-Fc), manufactured in mammalian cells. |
| REC31916-200 | Recombinant Mouse IgE-Fc domain | Recombinant mouse Immunoglobulin epsilon heavy chain constant region (IgE-Fc), manufactured in mammalian cells. |
| REC31917-200 | Recombinant Dog IgE-Fc domain | Recombinant dog Immunoglobulin epsilon heavy chain constant region (IgE-Fc), manufactured in mammalian cells. |
| REC31919-200 | Recombinant Horse IgE-Fc domain | Recombinant Horse immunoglobulin E (allotype A) heavy chain constant region (IgE Fc) (His tagged), manufactured in mammalian cells. |
| REC31918-200 | Recombinant Cat IgE-Fc domain | Recombinant cat Immunoglobulin epsilon heavy chain constant region (IgE-Fc), manufactured in mammalian cells. |
| REC31910-500 | Rotavirus VP7 Protein, Sheep Fc-Tag | Rotavirus structural glycoprotein VP7, expressed in HEK293 cells and purified from culture supernatant by Protein G and ion exchange chromatography. |
| REC31910-100 | Rotavirus VP7 Protein, Sheep Fc-Tag | Rotavirus structural glycoprotein VP7, expressed in HEK293 cells and purified from culture supernatant by Protein G and ion exchange chromatography. |
| REC31912-100 | Porcine Parvovirus 2 Capsid Protein 1 (Insect Cells), His-Tag | Recombinant Porcine Parvovirus 2 (PPV2) capsid protein 1 manufactured using the baculovirus expression system. |
| REC31912-500 | Porcine Parvovirus 2 Capsid Protein 1 (Insect Cells), His-Tag | Recombinant Porcine Parvovirus 2 (PPV2) capsid protein 1 manufactured using the baculovirus expression system. |
| REC31913-100 | Porcine Epidemic Diarrhea Virus Nucleoprotein (Insect Cells), His-Tag | Recombinant Porcine Epidemic Diarrhea Virus (PEDV) antigen is a recombinant nucleocapsid or N protein derived from Porcine Epidemic Diarrhea Virus and manufactured using the baculovirus expression system. |
| REC31913-500 | Porcine Epidemic Diarrhea Virus Nucleoprotein (Insect Cells), His-Tag | Recombinant Porcine Epidemic Diarrhea Virus (PEDV) antigen is a recombinant nucleocapsid or N protein derived from Porcine Epidemic Diarrhea Virus and manufactured using the baculovirus expression system. |
| REC31911-100 | Porcine Circovirus 2 Capsid Protein (E. coli), His-Tag | Recombinant porcine circovirus 2 (PCV2) antigen. |
| REC31911-500 | Porcine Circovirus 2 Capsid Protein (E. coli), His-Tag | Recombinant porcine circovirus 2 (PCV2) antigen. |
| DIP-TNL-1000 | Diphtheria Toxin | Purified diphtheria toxin from Corynebacterium diphtheriae. |
| DIP-TNL-100 | Diphtheria Toxin | Purified diphtheria toxin from Corynebacterium diphtheriae. |
| PT-TNG-50 | Bordetella Pertussis Toxin (Glycerol) | Purified native pertussis toxin from Bordetella pertussis, in glycerol buffer for repeated use and freeze/thawing, CHO cluster assay tested. |
| PT-TNG-200 | Bordetella Pertussis Toxin (Glycerol) | Purified native pertussis toxin from Bordetella pertussis, in glycerol buffer for repeated use and freeze/thawing, CHO cluster assay tested. |
| REC31639-100 | Crimean Congo Hemorrhagic Fever Virus Nucleoprotein | Recombinant Crimean Congo Hemorraghic Fever Virus Nucleoprotein. |
| REC31639-500 | Crimean Congo Hemorrhagic Fever Virus Nucleoprotein | Recombinant Crimean Congo Hemorraghic Fever Virus Nucleoprotein. |
| ZIKV-VLP-250 | Zika Virus VLP (E, prM/M Proteins) | Recombinant Zika Virus serotype 1 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. |
| REC31608-500 | Lassa Fever Virus GP2 Protein (Human Fc) | Recombinant Lassa Fever Virus GP2 protein produced in 293 human cells. Protein contains a c-terminal Human-Fc-tag. |
| ZIKVSU-ENV-100 | Zika Virus Envelope Protein (Suriname strain) | Recombinant Zika virus envelope protein expressed in HEK293 mammalian cells, with C terminal 6-His tag. |
| ZIKVSU-ENV-500 | Zika Virus Envelope Protein (Suriname strain) | Recombinant Zika virus envelope protein expressed in HEK293 mammalian cells, with C terminal 6-His tag |
| ZIKV-VLP-100 | Zika Virus VLP (E, prM/M Proteins) | Recombinant Zika Virus serotype 1 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. |
| REC31608-100 | Lassa Fever Virus GP2 Protein (Human Fc) | Recombinant Lassa Fever Virus GP2 protein produced in 293 human cells. Protein contains a c-terminal Human-Fc-tag. |
| REC31608-HRP-100 | Lassa Fever Virus GP2: HRP Conjugate | Recombinant Lassa Fever Virus GP2 protein produced in 293 human cells. Protein contains a C-terminal Human Fc-tag, conjugated to horseradish peroxidase (HRP). |
| REC31608-HRP-500 | Lassa Fever Virus GP2: HRP Conjugate | Recombinant Lassa Fever Virus GP2 protein produced in 293 human cells. Protein contains a C-terminal Human Fc-tag, conjugated to horseradish peroxidase (HRP). |
| REC31806-HRP-500 | SARS-CoV-2 Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293): Horseradish Peroxidase | Recombinant SARS-CoV-2 Spike Glycoprotein S1 (NCBI accession number YP_009724390.1, AA1-674), C-terminally tagged with a dimeric sheep Fc-tag. Protein was produced in HEK293 cells and purified from culture supernatant by Protein G chromatography, and then |
| REC31909-500 | Influenza B [B/Beijing/184/1993] Nucleoprotein | Influenza B recombinant nucleoprotein expressed and purified from Escherichia coli. |
| REC31909-100 | Influenza B [B/Beijing/184/1993] Nucleoprotein | Influenza B recombinant nucleoprotein expressed and purified from Escherichia coli. |
| NAT41629-100 | Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate | Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
| NAT41641-100 | Influenza A [A/Hong Kong/8/1968 (H3N2)] Viral Lysate | Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
| NAT41634-100 | Influenza A [A/California/07/2009 (H1N1pdm)] Viral Lysate | Influenza A H1N1 Pandemic 2009 (H1N1pdm) virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
| NAT41629-500 | Influenza A [A/New Caledonia/20/1999 (H1N1)] Viral Lysate | Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
| NAT41634-500 | Influenza A [A/California/07/2009 (H1N1pdm)] Viral Lysate | Influenza A H1N1 Pandemic 2009 (H1N1pdm) virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
| NAT41641-500 | Influenza A [A/Hong Kong/8/1968 (H3N2)] Viral Lysate | Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
| NAT41653-100 | Influenza B [B/Massachusetts/2/2012] Viral Lysate | Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
| NAT41653-500 | Influenza B [B/Massachusetts/2/2012] Viral Lysate | Influenza virus is propagated in the MDCK cell line. Virus is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated. |
| REC31907-100 | Varicella-Zoster Virus Heterodimer gE/gI (HEK293), His-tag | Varicella Zoster virus glycoprotein E (gE) glycoprotein I (gI) heterodimer. The heterodimer is labelled with a C-terminal His-tag on gE only. The protein complex was produced in HEK293 cells and purified from culture supernatant by immobilised metal affin |
| REC31907-500 | Varicella-Zoster Virus Heterodimer gE/gI (HEK293), His-tag | Varicella Zoster virus glycoprotein E (gE) glycoprotein I (gI) heterodimer. The heterodimer is labelled with a C-terminal His-tag on gE only. The protein complex was produced in HEK293 cells and purified from culture supernatant by immobilised metal affin |
| REC31870-500 | SARS-CoV-2 Spike Glycoprotein (S2), Sheep Fc-Tag (CHO) | Recombinant SARS-CoV-2 Spike Glycoprotein S2, C-terminally tagged with a sheep Fc-tag. Protein was produced in CHO cells and purified from culture supernatant by Protein G chromatography. |
| REC31870-100 | SARS-CoV-2 Spike Glycoprotein (S2), Sheep Fc-Tag (CHO) | Recombinant SARS-CoV-2 Spike Glycoprotein S2, C-terminally tagged with a sheep Fc-tag. Protein was produced in CHO cells and purified from culture supernatant by Protein G chromatography. |
| REC31869-500 | SARS-CoV-2 Spike Glycoprotein (S1), Sheep Fc-Tag (CHO) | Recombinant SARS-CoV-2 Spike Glycoprotein S1, C-terminally tagged with a sheep Fc-tag. Protein was produced in CHO cells and purified from culture supernatant by Protein G chromatography. |
| REC31869-100 | SARS-CoV-2 Spike Glycoprotein (S1), Sheep Fc-Tag (CHO) | Recombinant SARS-CoV-2 Spike Glycoprotein S1, C-terminally tagged with a sheep Fc-tag. Protein was produced in CHO cells and purified from culture supernatant by Protein G chromatography. |
| NAT41586-100 | Diphtheria Toxoid | Purified diphtheria toxin from Corynebacterium diphtheria strain NCTC 10648; converted to inactive toxoid form. |
| NAT41586-500 | Diphtheria Toxoid | Purified diphtheria toxin from Corynebacterium diphtheria strain NCTC 10648; converted to inactive toxoid form. |
| REC31905-100 | SARS-CoV-2 Spike N-Terminal Domain (NTD), His-Tag (HEK293) | SARS-CoV-2 N-terminal domain (NTD) of the Spike protein carrying a C-terminal His-tag produced in HEK293 cells and purified from culture supernatant by immobilised metal affinity and anion exchange chromatography. |
| REC31905-500 | SARS-CoV-2 Spike N-Terminal Domain (NTD), His-Tag (HEK293) | SARS-CoV-2 N-terminal domain (NTD) of the Spike protein carrying a C-terminal His-tag produced in HEK293 cells and purified from culture supernatant by immobilised metal affinity and anion exchange chromatography. |
| REC31903-500 | SARS-CoV-2 (D614G, V445I, H655Y, E583D Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing D614G, V445I, H655Y and E583D amino acid changes relative to the Wuhan-Hu-1 isolate. The D614G isolate has been reported to show increased virus transmissibility. |
| REC31903-100 | SARS-CoV-2 (D614G, V445I, H655Y, E583D Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing D614G, V445I, H655Y and E583D amino acid changes relative to the Wuhan-Hu-1 isolate. The D614G isolate has been reported to show increased virus transmissibility. |
| REC31899-500 | SARS-CoV-2 (D614G, S477N Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing both D614G and S477N amino acid changes relative to the Wuhan-Hu-1 isolate. The D614G isolate has been reported to show increased virus transmissibility. |
| REC31902-500 | SARS-CoV-2 (D614G, E484K Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing both D614G and E484K amino acid changes relative to the Wuhan-Hu-1 isolate. The D614G isolate has been reported to show increased virus transmissibility. |
| REC31902-100 | SARS-CoV-2 (D614G, E484K Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing both D614G and E484K amino acid changes relative to the Wuhan-Hu-1 isolate. The D614G isolate has been reported to show increased virus transmissibility. |
| REC31901-100 | SARS-CoV-2 (D614G, G485R Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing both D614G and G485R amino acid changes relative to the Wuhan-Hu-1 isolate. The D614G isolate has been reported to show increased virus transmissibility. |
| REC31900-100 | SARS-CoV-2 (D614G, L84I, N439K Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing D614G, L84I and N439K amino acid changes relative to the Wuhan-Hu-1 isolate. The D614G isolate has been reported to show increased virus transmissibility. |
| REC31899-100 | SARS-CoV-2 (D614G, S477N Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing both D614G and S477N amino acid changes relative to the Wuhan-Hu-1 isolate. The D614G isolate has been reported to show increased virus transmissibility. |
| REC31901-500 | SARS-CoV-2 (D614G, G485R Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing both D614G and G485R amino acid changes relative to the Wuhan-Hu-1 isolate. The D614G isolate has been reported to show increased virus transmissibility. |
| REC31900-500 | SARS-CoV-2 (D614G, L84I, N439K Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | SARS-CoV-2 Spike protein S1 containing D614G, L84I and N439K amino acid changes relative to the Wuhan-Hu-1 isolate. The D614G isolate has been reported to show increased virus transmissibility. |
| REC31897-500 | Human Coronavirus HKU1 Spike Glycoprotein (S1), His-Tag (HEK293) | Human coronavirus HKU1 Spike protein, subunit 1 (S1). The protein was expressed in HEK293 cells and purified from culture supernatant by immobilized metal affinity chromatography, followed by ion exchange chromatography and dialysis. |
| REC31897-100 | Human Coronavirus HKU1 Spike Glycoprotein (S1), His-Tag (HEK293) | Human coronavirus HKU1 Spike protein, subunit 1 (S1). The protein was expressed in HEK293 cells and purified from culture supernatant by immobilized metal affinity chromatography, followed by ion exchange chromatography and dialysis. |
| REC31896-500 | Human Coronavirus NL63 Spike Glycoprotein (S1), His-Tag (HEK293) | Human coronavirus NL63 Spike protein, subunit 1 (S1). The protein was expressed in HEK293 cells and purified from culture supernatant by immobilized metal affinity chromatography, followed by dialysis. |
| REC31896-100 | Human Coronavirus NL63 Spike Glycoprotein (S1), His-Tag (HEK293) | Human coronavirus NL63 Spike protein, subunit 1 (S1). The protein was expressed in HEK293 cells and purified from culture supernatant by immobilized metal affinity chromatography, followed by dialysis. |
| REC31892-100 | Influenza A [A/swine/Shandong/1207/2016 (H1N1)] Hemagglutinin (HA), His-Tag | Influenza A haemagglutinin protein (ectodomain) expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and buffer exchange. The protein contains a C-terminal His-tag. This virus strain is commonly call |
| REC31885-100 | Influenza A [A/Hawaii/70/2019 (H1N1)pdm09-like virus] Neuraminidase (NA), His-Tag | Influenza A neuraminidase protein (ectodomain) expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and buffer exchange. The protein contains a C-terminal His-tag. |
| REC31885-500 | Influenza A [A/Hawaii/70/2019 (H1N1)pdm09-like virus] Neuraminidase (NA), His-Tag | Influenza A neuraminidase protein (ectodomain) expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and buffer exchange. The protein contains a C-terminal His-tag. |
| REC31886-100 | Influenza A [A/Hong Kong/45/2019 (H3N2)] Hemagglutinin (HA), His-Tag | Influenza A haemagglutinin protein (ectodomain) expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and buffer exchange. The protein contains a C-terminal His-tag. |
| REC31886-500 | Influenza A [A/Hong Kong/45/2019 (H3N2)] Hemagglutinin (HA), His-Tag | Influenza A haemagglutinin protein (ectodomain) expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and buffer exchange. The protein contains a C-terminal His-tag. |
| REC31889-100 | Influenza B [B/Washington/02/2019] Neuraminidase (NA), His-Tag | Influenza B neuraminidase protein (ectodomain) expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and buffer exchange. The protein contains a C-terminal His-tag. |
| REC31889-500 | Influenza B [B/Washington/02/2019] Neuraminidase (NA), His-Tag | Influenza B neuraminidase protein (ectodomain) expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and buffer exchange. The protein contains a C-terminal His-tag. |
| REC31890-500 | Influenza B [B/Palermo/4/2013] Hemagglutinin (HA), His-Tag | Influenza B haemagglutinin protein (ectodomain) expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and buffer exchange. The protein contains a C-terminal His-tag. |
| REC31892-500 | Influenza A [A/swine/Shandong/1207/2016 (H1N1)] Hemagglutinin (HA), His-Tag | Influenza A haemagglutinin protein (ectodomain) expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and buffer exchange. The protein contains a C-terminal His-tag. This virus strain is commonly call |
| REC31890-100 | Influenza B [B/Palermo/4/2013] Hemagglutinin (HA), His-Tag | Influenza B haemagglutinin protein (ectodomain) expressed in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography and buffer exchange. The protein contains a C-terminal His-tag. |
| REC31895-100 | Human Coronavirus 229E Spike Glycoprotein (S1), His-Tag (HEK293) | Human coronavirus 229E Spike subunit 1 (S1) protein, expressed in HEK293 cells and purified from culture supernatant by immobilized metal affinity chromatography, followed by dialysis. |
| REC31894-500 | Human Coronavirus OC43 Spike Glycoprotein (S1), His-Tag (HEK293) | Human coronavirus OC43 Spike S1 subunit, expressed in HEK293 cells and purified from culture supernatant by immobilized metal affinity chromatography, followed by dialysis. |
| REC31895-500 | Human Coronavirus 229E Spike Glycoprotein (S1), His-Tag (HEK293) | Human coronavirus 229E Spike subunit 1 (S1) protein, expressed in HEK293 cells and purified from culture supernatant by immobilized metal affinity chromatography, followed by dialysis. |
| REC31894-100 | Human Coronavirus OC43 Spike Glycoprotein (S1), His-Tag (HEK293) | Human coronavirus OC43 Spike S1 subunit, expressed in HEK293 cells and purified from culture supernatant by immobilized metal affinity chromatography, followed by dialysis. |
| NAT41622-500 | Human Parainfluenza Virus Type 4A Lysate | Parainfluenza Virus is an enveloped, negative-sense single-stranded RNA virus with a diameter of approximately 150 to 250 nm. |
| NAT41626-500 | Rhinovirus Type 1A Lysate | Rhinovirus consists of a non-enveloped capsid containing a positive-sense single-stranded RNA. |
| NAT41626-100 | Rhinovirus Type 1A Lysate | Rhinovirus consists of a non-enveloped capsid containing a positive-sense single-stranded RNA. |
| NAT41625-500 | Respiratory Syncytial Virus B Lysate | Respiratory Syncytial Virus Type B (RSV-B, Strain CH93 (18)-18) is an enveloped Paramyxovirus that contains a helical nucleocapsid and negative-sense, single-stranded linear RNA. |
| NAT41625-100 | Respiratory Syncytial Virus B Lysate | Respiratory Syncytial Virus Type B (RSV-B, Strain CH93 (18)-18) is an enveloped Paramyxovirus that contains a helical nucleocapsid and negative-sense, single-stranded linear RNA. |
| NAT41624-500 | Respiratory Syncytial Virus A Lysate | Respiratory Syncytial Virus Type A (RSV-A, 2006 Isolate) is an enveloped Paramyxovirus that contains a helical nucleocapsid and negative-sense, single-stranded linear RNA. |
| NAT41624-100 | Respiratory Syncytial Virus A Lysate | Respiratory Syncytial Virus Type A (RSV-A, 2006 Isolate) is an enveloped Paramyxovirus that contains a helical nucleocapsid and negative-sense, single-stranded linear RNA. |
| NAT41621-100 | Human Parainfluenza Virus Type 3 Lysate | Parainfluenza Virus is an enveloped, negative-sense single-stranded RNA virus with a diameter of approximately 150 to 250 nm. |
| NAT41621-500 | Human Parainfluenza Virus Type 3 Lysate | Parainfluenza Virus is an enveloped, negative-sense single-stranded RNA virus with a diameter of approximately 150 to 250 nm. |
| NAT41622-100 | Human Parainfluenza Virus Type 4A Lysate | Parainfluenza Virus is an enveloped, negative-sense single-stranded RNA virus with a diameter of approximately 150 to 250 nm. |
| REC31893-500 | Influenza A [A/swine/Shandong/1207/2016 (H1N1)] Neuraminidase (NA), His-Tag | Swine influenza A virus Shandong/1207/2016 neuraminidase protein produced in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography. This virus strain is commonly called G4 reassortant, and contains genes from the |
| REC31884-100 | Influenza A [A/Hawaii/70/2019 (H1N1)pdm09-like virus] Hemagglutinin (HA), His-Tag | Influenza A virus H1N1 (Hawaii/70/2019) haemagglutinin, produced in HEK293 cells and purified from culture supernatant. This strain is part of the WHO vaccine recommendation for the Northern Hemisphere 2020/2021 season |
| REC31883-500 | SARS-CoV-2 (D614G Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | Recombinant SARS-CoV-2 Spike Glycoprotein S1 containing the D614G mutation relative to Wuhan-Hu-1. Protein was produced in HEK293 cells and purified from culture supernatant by Protein G chromatography. |
| REC31883-100 | SARS-CoV-2 (D614G Mutant) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | Recombinant SARS-CoV-2 Spike Glycoprotein S1 containing the D614G mutation relative to Wuhan-Hu-1. Protein was produced in HEK293 cells and purified from culture supernatant by Protein G chromatography. |
| REC31884-500 | Influenza A [A/Hawaii/70/2019 (H1N1)pdm09-like virus] Hemagglutinin (HA), His-Tag | Influenza A virus H1N1 (Hawaii/70/2019) haemagglutinin, produced in HEK293 cells and purified from culture supernatant. This strain is part of the WHO vaccine recommendation for the Northern Hemisphere 2020/2021 season. |
| REC31887-500 | Influenza A [A/Hong Kong/45/2019 (H3N2)] Neuraminidase (NA), His-Tag | Influenza A virus Hong Kong/45/2019 (H3N2) haemagglutinin, produced in HEK293 cells and purified from culture supernatant. This strain is part of the WHO vaccine recommendation for the Northern Hemisphere 2020/2021 season. |
| REC31888-100 | Influenza B [B/Washington/02/2019] Hemagglutinin (HA), His-Tag | Influenza B virus Washington/02/2019 haemagglutinin, produced in HEK293 cells and purified from culture supernatant. This strain is part of the WHO vaccine recommendation for the Northern Hemisphere 2020/2021 season. |
| REC31888-500 | Influenza B [B/Washington/02/2019] Hemagglutinin (HA), His-Tag | Influenza B virus Washington/02/2019 haemagglutinin, produced in HEK293 cells and purified from culture supernatant. This strain is part of the WHO vaccine recommendation for the Northern Hemisphere 2020/2021 season. |
| REC31891-100 | Influenza B [B/Victoria/35/2013] Neuraminidase (NA), His-Tag | Influenza B virus Victoria/35/2013 neuraminidase produced in HEK293 cells and purified from culture supernatant using immobilised metal affinity chromatography and buffer exchange. |
| REC31891-500 | Influenza B [B/Victoria/35/2013] Neuraminidase (NA), His-Tag | Influenza B virus Victoria/35/2013 neuraminidase produced in HEK293 cells and purified from culture supernatant using immobilised metal affinity chromatography and buffer exchange. |
| REC31893-100 | Influenza A [A/swine/Shandong/1207/2016 (H1N1)] Neuraminidase (NA), His-Tag | Swine influenza A virus Shandong/1207/2016 neuraminidase protein produced in HEK293 cells and purified from culture supernatant by immobilised metal affinity chromatography. This virus strain is commonly called G4 reassortant, and contains genes from the |
| REC31882-100 | SARS-CoV-2 Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | SARS-CoV-2 Spike protein receptor binding domain (RBD) produced in HEK293 cells. The protein was purified from culture supernatant by immobilised metal affinity chromatography |
| REC31882-500 | SARS-CoV-2 Spike Glycoprotein (S1) RBD, His-Tag (HEK293) | SARS-CoV-2 Spike protein receptor binding domain (RBD) produced in HEK293 cells. The protein was purified from culture supernatant by immobilised metal affinity chromatography |
| NAT41614-500 | Human Metapneumovirus (hMPV) 9 Type A1 Lysate | Human Metapneumovirus (hMPV) 9 Type A1 (Strain: IA3-2002) is propagated in the LLC-mk2 cell line. |
| NAT41614-100 | Human Metapneumovirus (hMPV) 9 Type A1 Lysate | Human Metapneumovirus (hMPV) 9 Type A1 (Strain: IA3-2002) is propagated in the LLC-mk2 cell line. |
| NAT41610-500 | Human Metapneumovirus (hMPV) 3 Type B1 Lysate | Human Metapneumovirus (hMPV) 3 Type B1 (Strain: Peru2-2002) is propagated in the LLC-mk2 cell line. |
| NAT41610-100 | Human Metapneumovirus (hMPV) 3 Type B1 Lysate | Human Metapneumovirus (hMPV) 3 Type B1 (Strain: Peru2-2002) is propagated in the LLC-mk2 cell line. |
| REC31880-500 | Human Coronavirus 229E Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293) | The human coronavirus 229E Spike protein soluble domain has been C-terminally tagged with a sheep Fc-tag. Amino acids 533-540 have been replaced with 9 AA glycine-serine linker to prevent protein cleavage by host cell proteases |
| REC31879-500 | Human Coronavirus NL63 Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293) | HCoV-NL63 soluble Spike protein was expressed in HEK293 cells and purified from culture supernatant by Protein G chromatography. AA 714-721 were replaced by an 8 AA glycine-serine linker to prevent proteolytic cleavage of the protein into S1 and S2 |
| REC31879-100 | Human Coronavirus NL63 Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293) | HCoV-NL63 soluble Spike protein was expressed in HEK293 cells and purified from culture supernatant by Protein G chromatography. AA 714-721 were replaced by an 8 AA glycine-serine linker to prevent proteolytic cleavage of the protein into S1 and S2 |
| REC31880-100 | Human Coronavirus 229E Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293) | The human coronavirus 229E Spike protein soluble domain has been C-terminally tagged with a sheep Fc-tag. Amino acids 533-540 have been replaced with 9 AA glycine-serine linker to prevent protein cleavage by host cell proteases |
| REC31856-100 | Human Coronavirus HKU1 Nucleoprotein, His-Tag (E. coli) | Recombinant human coronavirus HKU1 nucleoprotein expressed in Escherichia coli. The protein was purified by immobilised metal affinity chromatography and dialysis |
| REC31856-500 | Human Coronavirus HKU1 Nucleoprotein, His-Tag (E. coli) | Recombinant human coronavirus HKU1 nucleoprotein expressed in Escherichia coli. The protein was purified by immobilised metal affinity chromatography and dialysis |
| REC31881-50 | SARS-CoV-2 RBD-Nucleoprotein Chimera, His-Tag (CHO) | Recombinant SAR-CoV-2 N-terminal Spike S1 RBD (319-541) fused to full-length Nucleoprotein (Nucleocapsid) with a linker HSA (human serum albumin), expressed in CHO cells using a C-terminal His-tag |
| REC31881-20 | SARS-CoV-2 RBD-Nucleoprotein Chimera, His-Tag (CHO) | Recombinant SAR-CoV-2 N-terminal Spike S1 RBD (319-541) fused to full-length Nucleoprotein (Nucleocapsid) with a linker HSA (human serum albumin), expressed in CHO cells using a C-terminal His-tag |
| REC31881-100 | SARS-CoV-2 RBD-Nucleoprotein Chimera, His-Tag (CHO) | Recombinant SAR-CoV-2 N-terminal Spike S1 RBD (319-541) fused to full-length Nucleoprotein (Nucleocapsid) with a linker HSA (human serum albumin), expressed in CHO cells using a C-terminal His-tag |
| REC31881-10 | SARS-CoV-2 RBD-Nucleoprotein Chimera, His-Tag (CHO) | Recombinant SAR-CoV-2 N-terminal Spike S1 RBD (319-541) fused to full-length Nucleoprotein (Nucleocapsid) with a linker HSA (human serum albumin), expressed in CHO cells using a C-terminal His-tag |
| REC31851-Biotin-100 | SARS-CoV-2 Nucleoprotein, His-Tag (E. coli): Biotin Conjugate | Recombinant SARS-CoV-2 full-length nucleoprotein, expressed and purified from E. coli with a 6xHis-tag. Protein is biotinylated. |
| REC31877-100 | Human Coronavirus OC43 Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293) | Human coronavirus OC43 Spike protein expressed in HEK293 cells and purified from culture supernatant. The furin cleavage site at AA754-757 has been replaced with the sequence TTQT |
| REC31876-100 | Human ACE2 (18-615) Recombinant Protein, Sheep Fc-Tag (HEK293) | Human ACE2 was produced in HEK293 cells by transient transfection. The protein was C-terminally truncated to remove both the ADAM17 and TMPRSS2 cleavage sites. The protein was then purified from culture supernatant by Protein G chromatography |
| REC31876-500 | Human ACE2 (18-615) Recombinant Protein, Sheep Fc-Tag (HEK293) | Human ACE2 was produced in HEK293 cells by transient transfection. The protein was C-terminally truncated to remove both the ADAM17 and TMPRSS2 cleavage sites. The protein was then purified from culture supernatant by Protein G chromatography |
| REC31877-500 | Human Coronavirus OC43 Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293) | Human coronavirus OC43 Spike protein expressed in HEK293 cells and purified from culture supernatant. The furin cleavage site at AA754-757 has been replaced with the sequence TTQT |
| REC31876-20 | Human ACE2 (18-615) Recombinant Protein, Sheep Fc-Tag (HEK293) | Human ACE2 was produced in HEK293 cells by transient transfection. The protein was C-terminally truncated to remove both the ADAM17 and TMPRSS2 cleavage sites. The protein was then purified from culture supernatant by Protein G chromatography |
| REC31868-HRP-100 | SARS-CoV-2 Spike Glycoprotein (Full-Length), His-Tag (CHO): HRP Conjugate | Recombinant full-length Spike protein (soluble domain). The furin cleavage site (AA 682-685) has been mutated from RRAR to SRAS and the transmembrane domain and intravirion part was replaced with a glycine-serine linker and a His-tag. Conjugated to Horser |
| REC31851-HRP-100 | SARS-CoV-2 Nucleoprotein, His-Tag (E. coli): HRP Conjugate | Recombinant SARS-CoV-2 full-length nucleoprotein, expressed and purified from E. coli with a 6xHis-tag. Protein is conjugated to Horseradish Peroxidase (HRP). |
| REC31873-20 | SARS-CoV-2 Papain-Like Protease (PLpro), Active | Recombinant SARS-CoV-2 papain-like protease (PLpro), part of the large replicase polyprotein 1ab (E1564-Y1882), expressed in E. coli cells with an N-terminal His-tag. |
| REC31875-50 | SARS-CoV-2 3C-Like Proteinase (3CLpro), Active | Recombinant full-length 2019nCoV 3CLpro, part of the large replicase polyprotein 1ab (S3264-Q3569), expressed in E. coli cells with an N-terminal His-tag. |
| REC31875-20 | SARS-CoV-2 3C-Like Proteinase (3CLpro), Active | Recombinant full-length 2019nCoV 3CLpro, part of the large replicase polyprotein 1ab (S3264-Q3569), expressed in E. coli cells with an N-terminal His-tag. |
| REC31874-50 | SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp) , Active | Recombinant full-length SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) was expressed in E. coli cells using a C-terminal His-tag. |
| REC31874-20 | SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp) , Active | Recombinant full-length SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) was expressed in E. coli cells using a C-terminal His-tag. |
| REC31873-50 | SARS-CoV-2 Papain-Like Protease (PLpro), Active | Recombinant SARS-CoV-2 papain-like protease (PLpro), part of the large replicase polyprotein 1ab (E1564-Y1882), expressed in E. coli cells with an N-terminal His-tag. |
| REC31872-20 | Human CD147 (22-205) Recombinant Protein, Fc-Tag (CHO) | Recombinant human CD147 protein (amino acids 22-205) expressed in CHO cells with a C-terminal Fc-tag |
| REC31874-10 | SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp) , Active | Recombinant full-length SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) was expressed in E. coli cells using a C-terminal His-tag. |
| REC31872-50 | Human CD147 (22-205) Recombinant Protein, Fc-Tag (CHO) | Recombinant human CD147 protein (amino acids 22-205) expressed in CHO cells with a C-terminal Fc-tag |
| REC31857-500 | Human Coronavirus OC43 Nucleoprotein, His-Tag (E. coli) | Recombinant human coronavirus OC43 (HCoV43) nucleoprotein expressed in Escherichia coli. The protein was purified by immobilised metal affinity chromatography and dialysis. |
| REC31857-100 | Human Coronavirus OC43 Nucleoprotein, His-Tag (E. coli) | Recombinant human coronavirus OC43 (HCoV43) nucleoprotein expressed in Escherichia coli. The protein was purified by immobilised metal affinity chromatography and dialysis. |
| REC31871-500 | SARS-CoV-2 Spike Glycoprotein (Trimeric), His-Tag (CHO) | Trimeric SARS-CoV-2 spike protein in prefusion confirmation. C-terminal transmembrane region is replaced with a trimerization domain and a polyhistidine tag. Contains two stabilizing proline mutations and scrambled S1/S2 furin cleavage site (Wrapp et al., |
| REC31871-100 | SARS-CoV-2 Spike Glycoprotein (Trimeric), His-Tag (CHO) | Trimeric SARS-CoV-2 spike protein in prefusion confirmation. C-terminal transmembrane region is replaced with a trimerization domain and a polyhistidine tag. Contains two stabilizing proline mutations and scrambled S1/S2 furin cleavage site (Wrapp et al., |
| REC31898-500 | SARS-CoV-2 (D614G Mutant) Spike Glycoprotein (Trimeric), His-Tag (CHO) | Trimeric SARS-CoV-2 spike protein, with D614G mutation, in prefusion confirmation. C-terminal transmembrane region is replaced with a trimerization domain and a polyhistidine tag. Contains two stabilizing proline mutations and scrambled S1/S2 furin cleava |
| REC31898-100 | SARS-CoV-2 (D614G Mutant) Spike Glycoprotein (Trimeric), His-Tag (CHO) | Trimeric SARS-CoV-2 spike protein, with D614G mutation, in prefusion confirmation. C-terminal transmembrane region is replaced with a trimerization domain and a polyhistidine tag. Contains two stabilizing proline mutations and scrambled S1/S2 furin cleava |
| REC31898-1000 | SARS-CoV-2 (D614G Mutant) Spike Glycoprotein (Trimeric), His-Tag (CHO) | Trimeric SARS-CoV-2 spike protein, with D614G mutation, in prefusion confirmation. C-terminal transmembrane region is replaced with a trimerization domain and a polyhistidine tag. Contains two stabilizing proline mutations and scrambled S1/S2 furin cleava |
| REC31867-100 | Human Coronavirus HKU1 Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293) | Human coronavirus HKU1 Spike protein expressed in HEK293 cells and purified from culture supernatant. The furin cleavage site RKRR (AA753-756) has been replaced with the sequence TSQT. |
| REC31867-500 | Human Coronavirus HKU1 Spike Glycoprotein (Full-Length), Sheep Fc-Tag (HEK293) | Human coronavirus HKU1 Spike protein expressed in HEK293 cells and purified from culture supernatant. The furin cleavage site RKRR (AA753-756) has been replaced with the sequence TSQT. |
| NAT41609-100 | Diphtheria Toxoid (Frozen) | Diphtheria toxoid is a formaldehyde-inactivated toxin purified from Corynebacterium diphtheriae. |
| NAT41609-1000 | Diphtheria Toxoid (Frozen) | Diphtheria toxoid is a formaldehyde-inactivated toxin purified from Corynebacterium diphtheriae. |
| NAT41606-100 | Human Coronavirus OC43 Purified Viral Lysate | Coronavirus OC43 is a Group 2 CoV, propagated in the HCT-8 cell line. Viral lysate is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of detergent and heat inactivated. |
| NAT41608-500 | Human Coronavirus 229E Purified Viral Lysate | Coronavirus 229E is a Group 1 CoV, propagated in the HeLa or MRC-5 cell line. Viral lysate is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of detergent and heat inactivated. |
| NAT41607-100 | Human Coronavirus NL63 Purified Viral Lysate | Coronavirus NL63 is a Group 1 CoV, propagated in the Vero cell line. Viral lysate is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of detergent and heat inactivated. |
| NAT41608-100 | Human Coronavirus 229E Purified Viral Lysate | Coronavirus 229E is a Group 1 CoV, propagated in the HeLa or MRC-5 cell line. Viral lysate is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of detergent and heat inactivated. |
| NAT41607-500 | Human Coronavirus NL63 Purified Viral Lysate | Coronavirus NL63 is a Group 1 CoV, propagated in the Vero cell line. Viral lysate is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of detergent and heat inactivated. |
| NAT41606-500 | Human Coronavirus OC43 Purified Viral Lysate | Coronavirus OC43 is a Group 2 CoV, propagated in the HCT-8 cell line. Viral lysate is purified using sucrose density gradient ultracentrifugation, disrupted in the presence of detergent and heat inactivated. |
| REC31868-100 | SARS-CoV-2 Spike Glycoprotein (Full-Length), His-Tag (CHO) | Recombinant full-length Spike protein (soluble domain). The furin cleavage site (AA 682-685) has been mutated from RRAR to SRAS and the transmembrane domain and intravirion part was replaced with a glycine-serine linker and a His-tag. |
| REC31868-500 | SARS-CoV-2 Spike Glycoprotein (Full-Length), His-Tag (CHO) | Recombinant full-length Spike protein (soluble domain). The furin cleavage site (AA 682-685) has been mutated from RRAR to SRAS and the transmembrane domain and intravirion part was replaced with a glycine-serine linker and a His-tag. |
| NAT41605-500 | SARS-CoV-2 Purified Viral Lysate | This virus was isolated from a patient with a respiratory illness who had returned from travel to the affected region of China and developed COVID19 in January 2020 in Washington, USA. Sequence Strain: SARS-Related Coronavirus 2 (SARS-CoV-2, Isolate: USA |
| NAT41605-100 | SARS-CoV-2 Purified Viral Lysate | This virus was isolated from a patient with a respiratory illness who had returned from travel to the affected region of China and developed COVID19 in January 2020 in Washington, USA. Sequence Strain: SARS-Related Coronavirus 2 (SARS-CoV-2, Isolate: USA |
| REC31855-100 | MERS Coronavirus Spike Glycoprotein (S1), His-Tag (Insect Cells) | Middle East respiratory syndrome coronavirus (MERS-CoV) recombinant Spike sub-unit 1 protein, expressed in HEK293 cells by transient transfection using a heterologous signal sequence. |
| REC31859-500 | Human Coronavirus 229E Nucleoprotein, His-Tag (E. coli) | Recombinant human Coronavirus 229E (HCoV-229E) nucleoprotein, manufactured in E. coli. |
| REC31859-100 | Human Coronavirus 229E Nucleoprotein, His-Tag (E. coli) | Recombinant human Coronavirus 229E (HCoV-229E) nucleoprotein, manufactured in E. coli. |
| REC31851-500 | SARS-CoV-2 Nucleoprotein, His-Tag (E. coli) | Recombinant SARS-CoV-2 full-length nucleoprotein, expressed and purified from E. coli with a 6xHis-tag. |
| REC31851-100 | SARS-CoV-2 Nucleoprotein, His-Tag (E. coli) | Recombinant SARS-CoV-2 full-length nucleoprotein, expressed and purified from E. coli with a 6xHis-tag. |
| REC31803-1000 | Streptavidin-FITC Conjugate | Purified Streptavidin conjugated to Fluorescein isothiocyanate (FITC). |
| REC31804-1000 | Streptavidin-AP Conjugate | Purified Streptavidin conjugated to Alkaline Phosphatase (AP). |
| REC31805-1000 | Streptavidin-HRP Conjugate | Purified Streptavidin conjugated to Horseradish Peroxidase (HRP). |
| A40P-100 | Adenovirus Type 40 Antigen | Concentrated and purified Adenovirus type 40 virions from a caesium chloride density gradient banding of an optimally-infected 293-cell lysate. |
| REC31847-100 | MERS Coronavirus Spike Glycoprotein (S1), Camel Fc-Tag (HEK293) | Recombinant MERS-CoV Spike subunit 1 protein, with N-terminal dimeric Camel Fc-tag. |
| REC31832-100 | Human ACE2 (18-615) Recombinant Protein, Fc-Tag (CHO) | Recombinant human angiotensin-converting enzyme 2 (ACE2) extracellular domain (18-615) was expressed in CHO cells using a C-terminal Fc-tag. |
| REC31831-100 | SARS-CoV-2 Spike Glycoprotein (S1) RBD, His-Tag (CHO) | Recombinant SARS-CoV-2 Spike protein S1 subunit, receptor-binding domain (RBD) (319-541) was expressed in CHO cells using a C-terminal His-tag. |
| REC31831-500 | SARS-CoV-2 Spike Glycoprotein (S1) RBD, His-Tag (CHO) | Recombinant SARS-CoV-2 Spike protein S1 subunit, receptor-binding domain (RBD) (319-541) was expressed in CHO cells using a C-terminal His-tag. |
| REC31833-100 | Human ACE2 (19-740) Recombinant Protein, Fc-Tag (CHO) | Recombinant human angiotensin-converting enzyme 2 (ACE2) extracellular domain (19-740) was expressed in CHO cells using a C-terminal Fc-tag. |
| REC31844-100 | SARS-CoV-2 Spike Glycoprotein (S2) (aa 800-1000), His-Tag (E. coli) | Recombinant protein containing Spike immunodominant region (amino acids 800 to 1000), manufactured to high purity in E. coli. |
| REC31844-500 | SARS-CoV-2 Spike Glycoprotein (S2) (aa 800-1000), His-Tag (E. coli) | Recombinant protein containing Spike immunodominant region (amino acids 800 to 1000), manufactured to high purity in E. coli. |
| REC31846-100 | SARS-CoV-2 Spike Glycoprotein (S2) (aa 1000-1200), His-Tag (E. coli) | Recombinant protein containing Spike immunodominant region (aa 1000 to 1200), manufactured to high purity in E. coli. |
| REC31846-500 | SARS-CoV-2 Spike Glycoprotein (S2) (aa 1000-1200), His-Tag (E. coli) | Recombinant protein containing Spike immunodominant region (aa 1000 to 1200), manufactured to high purity in E. coli. |
| REC31843-20 | SARS-CoV-2 Spike Glycoprotein (S1) RBD, Fc-Tag (CHO) | Recombinant SARS-CoV-2 Spike protein S1 subunit, receptor-binding domain (RBD) (319-541) was expressed in CHO cells using a C-terminal Fc tag. |
| REC31843-100 | SARS-CoV-2 Spike Glycoprotein (S1) RBD, Fc-Tag (CHO) | Recombinant SARS-CoV-2 Spike protein S1 subunit, receptor-binding domain (RBD) (319-541) was expressed in CHO cells using a C-terminal Fc tag. |
| REC31835-100 | SARS-CoV-2 Spike N-Terminal Domain (NTD), Sheep Fc-Tag (HEK293) | Recombinant SARS-CoV-2 Spike protein N-terminal domain (NTD). This domain shows the lowest sequence ID compared to SARS-CoV Spike protein. The protein is produced in HEK293 cells and purified from culture supernatant by Protein G chromatography. |
| REC31835-500 | SARS-CoV-2 Spike N-Terminal Domain (NTD), Sheep Fc-Tag (HEK293) | Recombinant SARS-CoV-2 Spike protein N-terminal domain (NTD). This domain shows the lowest sequence ID compared to SARS-CoV Spike protein. The protein is produced in HEK293 cells and purified from culture supernatant by Protein G chromatography. |
| REC31837-500 | SARS Coronavirus Nucleoprotein (C-Term) (E. coli) | SARS associated coronavirus nucleocapsid recombinant antigen immunodominant region (aa 340-390). Immunoreactive with sera from SARS-infected individuals with minimum specificity problems. |
| REC31842-500 | SARS Coronavirus Spike Glycoprotein (S1) Mosaic (E. coli) | Recombinant protein manufactured in E. coli. Contains amino acids 408-470 and 540-573 of the Spike protein immunodominant region. Immunoreactive with sera from SARS-infected individuals. |
| REC31836-100 | SARS Coronavirus Nucleoprotein (N-Term) (E. coli) | SARS Coronavirus Nucleoprotein (N-Term), also known as the nucleocapsid core antigen, is a recombinant protein manufactured in E. coli, comprising immunodominant region aa 1-49. Immunoreactive with sera from SARS-infected individuals. |
| REC31837-100 | SARS Coronavirus Nucleoprotein (C-Term) (E. coli) | SARS associated coronavirus nucleocapsid recombinant antigen immunodominant region (aa 340-390). Immunoreactive with sera from SARS-infected individuals with minimum specificity problems. |
| REC31838-100 | SARS Coronavirus Membrane Protein (Matrix) (E. coli) | Recombinant protein manufactured in E. coli. Contains duplicate Membrane (also known as Matrix) immunodominant region sequences fused with a proprietary linker and His-tag. Immunoreactive with sera from SARS-infected individuals. |
| REC31838-500 | SARS Coronavirus Membrane Protein (Matrix) (E. coli) | Recombinant protein manufactured in E. coli. Contains duplicate Membrane (also known as Matrix) immunodominant region sequences fused with a proprietary linker and His-tag. Immunoreactive with sera from SARS-infected individuals. |
| REC31839-100 | SARS Coronavirus Envelope Protein (E. coli) | Recombinant protein manufactured in E. coli. Contains the N-terminus Envelope protein, 1-76 amino acids immunodominant regions. Immunoreactive with sera from SARS-infected individuals. |
| REC31839-500 | SARS Coronavirus Envelope Protein (E. coli) | Recombinant protein manufactured in E. coli. Contains the N-terminus Envelope protein, 1-76 amino acids immunodominant regions. Immunoreactive with sera from SARS-infected individuals. |
| REC31840-100 | SARS Coronavirus Spike Glycoprotein (S1) Mosaic (N-Term) (E. coli) | Recombinant protein manufactured in E. coli. Contains the N-terminal section of the Spike protein immunodominant regions (aa 1-53, 90-115, 171-205). Immunoreactive with sera from SARS-infected individuals. |
| REC31840-500 | SARS Coronavirus Spike Glycoprotein (S1) Mosaic (N-Term) (E. coli) | Recombinant protein manufactured in E. coli. Contains the N-terminal section of the Spike protein immunodominant regions (aa 1-53, 90-115, 171-205). Immunoreactive with sera from SARS-infected individuals. |
| REC31841-100 | SARS Coronavirus Spike Glycoprotein (S2) Mosaic (C-Term) (E. coli) | Recombinant protein manufactured in E. coli. Contains the C-terminal section of the Spike protein immunodominant regions. Immunoreactive with sera from SARS-infected individuals. |
| REC31841-500 | SARS Coronavirus Spike Glycoprotein (S2) Mosaic (C-Term) (E. coli) | Recombinant protein manufactured in E. coli. Contains the C-terminal section of the Spike protein immunodominant regions. Immunoreactive with sera from SARS-infected individuals. |
| REC31842-100 | SARS Coronavirus Spike Glycoprotein (S1) Mosaic (E. coli) | Recombinant protein manufactured in E. coli. Contains amino acids 408-470 and 540-573 of the Spike protein immunodominant region. Immunoreactive with sera from SARS-infected individuals. |
| REC31836-500 | SARS Coronavirus Nucleoprotein (N-Term) (E. coli) | SARS Coronavirus Nucleoprotein (N-Term), also known as the nucleocapsid core antigen, is a recombinant protein manufactured in E. coli, comprising immunodominant region aa 1-49. Immunoreactive with sera from SARS-infected individuals. |
| REC31833-20 | Human ACE2 (19-740) Recombinant Protein, Fc-Tag (CHO) | Recombinant human angiotensin-converting enzyme 2 (ACE2) extracellular domain (19-740) was expressed in CHO cells using a C-terminal Fc-tag. |
| REC31832-20 | Human ACE2 (18-615) Recombinant Protein, Fc-Tag (CHO) | Recombinant human angiotensin-converting enzyme 2 (ACE2) extracellular domain (18-615) was expressed in CHO cells using a C-terminal Fc-tag. |
| REC31831-20 | SARS-CoV-2 Spike Glycoprotein (S1) RBD, His-Tag (CHO) | Recombinant SARS-CoV-2 Spike protein S1 subunit, receptor-binding domain (RBD) (319-541) was expressed in CHO cells using a C-terminal His-tag. |
| REC31807-HRP-100 | SARS-CoV-2 Spike Glycoprotein (S2), Sheep Fc-Tag (HEK293): Horseradish Peroxidase | Recombinant SARS-CoV-2 Spike Glycoprotein S2 is C-terminally tagged with a dimeric sheep Fc-tag. Protein was produced in HEK293 cells and purified from culture supernatant by Protein G chromatography, and then conjugated to Horseradish peroxidase. |
| REC31806-Biotin-100 | SARS-CoV-2 Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293): Biotin | Recombinant SARS-CoV-2 Spike Glycoprotein S1 is C-terminally tagged with a dimeric sheep Fc-tag. Protein was produced in HEK293 cells and purified from culture supernatant by Protein G chromatography, and then biotinylated. |
| REC31807-Biotin-100 | SARS-CoV-2 Spike Glycoprotein (S2), Sheep Fc-Tag (HEK293): Biotin | Recombinant SARS-CoV-2 Spike Glycoprotein S2 is C-terminally tagged with a dimeric sheep Fc-tag. Protein was produced in HEK293 cells and purified from culture supernatant by Protein G chromatography, and then biotinylated. |
| REC31830-500 | SARS-CoV-2 Spike Glycoprotein (S2), His-Tag (Insect Cells) | Recombinant SARS-CoV-2 Spike S2 protein was produced in T. ni cells by infection with a recombinant baculovirus and purified from culture supernatant by immobilised metal affinity and ion exchange chromatography. |
| REC31830-100 | SARS-CoV-2 Spike Glycoprotein (S2), His-Tag (Insect Cells) | Recombinant SARS-CoV-2 Spike S2 protein was produced in T. ni cells by infection with a recombinant baculovirus and purified from culture supernatant by immobilised metal affinity and ion exchange chromatography. |
| REC31808-50 | SARS-CoV-2 Nucleoprotein, His-Tag (HEK293) | Recombinant SARS-CoV-2 Nucleoprotein produced in HEK293 cells and purified from transfected cells by immobilised metal affinity and ion exchange chromatography. |
| REC31809-500 | SARS Coronavirus Spike Glycoprotein (S1), His-Tag (HEK293) | Recombinant severe acute respiratory syndrome virus Spike S1 protein produced in HEK293 cells and purified from culture supernatant by immobilised metal affinity and ion exchange chromatography. |
| REC31809-100 | SARS Coronavirus Spike Glycoprotein (S1), His-Tag (HEK293) | Recombinant severe acute respiratory syndrome virus Spike S1 protein produced in HEK293 cells and purified from culture supernatant by immobilised metal affinity and ion exchange chromatography. |
| NAT41604-100 | Streptococcus Pneumoniae Antigen, Native Extract | Inactivated Streptococcus pneumoniae antigen from culture. |
| REC31828-100 | SARS-CoV-2 Spike Glycoprotein (S1), His-tag (Insect Cells) | Recombinant SARS-CoV-2 Spike Glycoprotein S1, C-terminally tagged with a 6xHis-tag. Protein was produced in insect cells and purified by metal affinity and ion exchange chromatography. |
| REC31828-500 | SARS-CoV-2 Spike Glycoprotein (S1), His-tag (Insect Cells) | Recombinant SARS-CoV-2 Spike Glycoprotein S1, C-terminally tagged with a 6xHis-tag. Protein was produced in insect cells and purified by metal affinity and ion exchange chromatography. |
| REC31829-100 | SARS-CoV-2 Spike-E-M Mosaic Protein, His-tag (E. coli) | Recombinant protein containing Spike (S), Envelope (E) and Membrane (M) immunodominant regions. Expressed and purified in E. coli with C-terminal His-tag. |
| REC31829-500 | SARS-CoV-2 Spike-E-M Mosaic Protein, His-tag (E. coli) | Recombinant protein containing Spike (S), Envelope (E) and Membrane (M) immunodominant regions. Expressed and purified in E. coli with C-terminal His-tag. |
| NAT41599-500 | Brucella Abortus Antigen | Brucella abortus lysate, produced by fermentation. |
| NAT41600-100 | Campylobacter Jejuni Antigen | Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
| NAT41600-500 | Campylobacter Jejuni Antigen | Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
| NAT41601-100 | Candida Albicans Antigen | Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
| NAT41601-500 | Candida Albicans Antigen | Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
| NAT41602-100 | Echinococcus Granulosus Antigen | Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
| NAT41602-500 | Echinococcus Granulosus Antigen | Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
| NAT41603-500 | Helicobacter Pylori Antigen | Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
| NAT41599-100 | Brucella Abortus Antigen | Brucella abortus lysate, produced by fermentation. |
| NAT41603-100 | Helicobacter Pylori Antigen | Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
| REC31827-500 | Toxoplasma gondii ROP1 Protein | Recombinant Toxoplasma gondii ROP1 contains the N-terminal sequence of the ROP1 protein. |
| REC31827-100 | Toxoplasma gondii ROP1 Protein | Recombinant Toxoplasma gondii ROP1 contains the N-terminal sequence of the ROP1 protein. |
| REC31826-500 | Toxoplasma gondii GRA7 Protein | Recombinant Toxoplasma gondii GRA7 is produced in E. coli and contains 146 amino acids from GRA7 protein, fused with a GST-tag. |
| REC31826-100 | Toxoplasma gondii GRA7 Protein | Recombinant Toxoplasma gondii GRA7 is produced in E. coli and contains 146 amino acids from GRA7 protein, fused with a GST-tag. |
| REC31825-500 | Toxoplasma gondii SAG2 Protein | Recombinant T. gondii SAG2 is expressed in E. coli and contains the full length SAG2 amino-acid sequence with a His-tag at its C-terminus. |
| REC31825-100 | Toxoplasma gondii SAG2 Protein | Recombinant T. gondii SAG2 is expressed in E. coli and contains the full length SAG2 amino-acid sequence with a His-tag at its C-terminus. |
| REC31765-100 | Borrelia Miyamotoi GlpQ Protein, His-tag | Recombinant full length Borrelia miyamotoi GlpQ (NCBI: WP_025443886.1) protein produced in E. coli cells. Protein contains a C-terminal His-tag. (10x). The protein was purified using immobilised metal affinity chromatography and ion exchange chromatograp |
| REC31765-500 | Borrelia Miyamotoi GlpQ Protein, His-tag | Recombinant full length Borrelia miyamotoi GlpQ (NCBI: WP_025443886.1) protein produced in E. coli cells. Protein contains a C-terminal His-tag. (10x). The protein was purified using immobilised metal affinity chromatography and ion exchange chromatograp |
| REC31744-500 | SARS Coronavirus Nucleoprotein (NP), His-tag (HEK293) | Recombinant severe acute respiratory syndrome virus (SARS-CoV) nucleoprotein, N-terminally tagged with a His-tag. Protein was produced in HEK293 cells and purified by immobilised metal affinity and ion exchange chromatography. |
| REC31744-100 | SARS Coronavirus Nucleoprotein (NP), His-tag (HEK293) | Recombinant severe acute respiratory syndrome virus (SARS-CoV) nucleoprotein, N-terminally tagged with a His-tag. Protein was produced in HEK293 cells and purified by immobilised metal affinity and ion exchange chromatography. |
| REC31810-100 | Mumps Virus Nucleoprotein (Strain Jeryl-Lynn) | Recombinant Mumps Virus Nucleoprotein (NCBI accession number AGC97158.1, AA1-549). Protein was produced in HEK293 cells and purified by repeated density gradient centrifugation. Protein is presented in 4M urea to prevent large-scale capsid formation. Dyna |
| REC31811-500 | Mumps Virus Nucleoprotein (Strain L-Zagreb) | Recombinant Mumps Virus Nucleoprotein (NCBI accession number AHA38270.1, AA1-549). Protein was produced in HEK293 cells and purified by repeated density gradient centrifugation. Protein is presented in 4M urea to prevent large-scale capsid formation. Dyna |
| REC31811-100 | Mumps Virus Nucleoprotein (Strain L-Zagreb) | Recombinant Mumps Virus Nucleoprotein (NCBI accession number AHA38270.1, AA1-549). Protein was produced in HEK293 cells and purified by repeated density gradient centrifugation. Protein is presented in 4M urea to prevent large-scale capsid formation. Dyna |
| REC31810-500 | Mumps Virus Nucleoprotein (Strain Jeryl-Lynn) | Recombinant Mumps Virus Nucleoprotein (NCBI accession number AGC97158.1, AA1-549). Protein was produced in HEK293 cells and purified by repeated density gradient centrifugation. Protein is presented in 4M urea to prevent large-scale capsid formation. Dyna |
| REC31806-100 | SARS-CoV-2 Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | Recombinant SARS-CoV-2 S1 glycoprotein (NCBI accession number YP_009724390.1, AA1-674), C-terminally tagged with a dimeric sheep Fc-tag. Protein was produced in HEK293 cells and purified from culture supernatant by Protein G chromatography. |
| REC31806-500 | SARS-CoV-2 Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | Recombinant SARS-CoV-2 S1 glycoprotein (NCBI accession number YP_009724390.1, AA1-674), C-terminally tagged with a dimeric sheep Fc-tag. Protein was produced in HEK293 cells and purified from culture supernatant by Protein G chromatography. |
| REC31807-100 | SARS-CoV-2 Spike Glycoprotein (S2), Sheep Fc-Tag (HEK293) | Recombinant SARS-CoV-2 S2 glycoprotein (NCBI accession number YP_009724390.1, AA676-1211), C-terminally tagged with a dimeric sheep Fc-tag. Protein was produced in HEK293 cells and purified from culture supernatant by Protein G chromatography. |
| REC31807-500 | SARS-CoV-2 Spike Glycoprotein (S2), Sheep Fc-Tag (HEK293) | Recombinant SARS-CoV-2 (NCBI accession number YP_009724390.1, AA676-1211), C-terminally tagged with a dimeric sheep Fc-tag. Protein was produced in HEK293 cells and purified from culture supernatant by Protein G chromatography. |
| NAT41598-100 | Feline Viral Rhinotracheitis Antigen | Feline Viral Rhinotracheitis (FVR; feline herpes virus, FHV-1) antigen, produced in CRFK cells. |
| NAT41596-100 | Feline Infectious Peritonitis Virus Antigen | Feline Infectious Peritonitis virus (FIPV; feline coronavirus) antigen, produced in CRFK cells. |
| NAT41594-100 | Canine Parvovirus Antigen | Canine Parvovirus, produced in CRFK cells. |
| NAT41597-100 | Feline Panleukopenia Virus Antigen | Feline Panleukopenia Virus (FPLV; feline parvovirus) antigen, produced in CRFK cells. |
| NAT41591-100 | Canine Distemper Virus Antigen | Canine Distemper virus, produced in SL-29 cells. |
| NAT41592-100 | Canine Herpes Virus Antigen | Canine Herpes virus, produced in MDCK cells. |
| NAT41588-100 | Canine Adenovirus 2 Antigen | Canine Adenovirus Type 2, produced in A-72 cells. |
| NAT41589-100 | Canine Adenovirus 1 and 2 Antigen | A mixture of Canine Adenovirus Type 1 and Type 2, produced in A-72 cells. |
| NAT41590-100 | Canine Coronavirus Antigen | Canine Coronavirus produced in A-72 cells. |
| NAT41587-100 | Canine Adenovirus 1 Antigen | Canine Adenovirus Type 1, produced in A-72 cells. |
| REC31801-500 | Tetanus Toxin, Recombinant Heavy Chain Fragment C | Recombinant carboxyl fragment of tetanus toxin heavy chain expressed in the cytoplasm of E. coli as a properly-folded, soluble protein. |
| REC31801-100 | Tetanus Toxin, Recombinant Heavy Chain Fragment C | Recombinant carboxyl fragment of tetanus toxin heavy chain expressed in the cytoplasm of E. coli as a properly-folded, soluble protein. |
| REC31802-50 | African Swine Fever Virus P30 (Insect Cells) | Recombinant African Swine Fever virus p30 protein, manufactured in insect cells and purified by affinity chromatography. |
| REC31743-500 | Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B] | Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected |
| REC31743-100 | Human Immunodeficiency Virus p24 Protein [HIV-1/Clade B] | Recombinant HIV p24 protein (NCBI accession number ABO61536, AA35-265, L40I) produced in HEK293 cells. Protein carries a C-terminal His-tag.. Protein was purified by immobilised metal affinity and ion exchange chromatography from the pellet of transfected |
| REC31800-200 | Diphtheria Toxin, CRM197 Mutant | CRM197 is a genetically detoxified diphtheria toxin. It is expressed as a soluble, correctly folded ~58kDa recombinant protein in the cytoplasm of E. coli and then produced to >99% purity. |
| REC31800-500 | Diphtheria Toxin, CRM197 Mutant | CRM197 is a genetically detoxified diphtheria toxin. It is expressed as a soluble, correctly folded ~58kDa recombinant protein in the cytoplasm of E. coli and then produced to >99% purity. |
| REC31798-100 | Yellow Fever virus Envelope protein, sheep Fc-tag | Recombinant Yellow Fever virus Envelope protein (NCBI accession number AWB15005, AA287-679) produced in insect cells. Protein contains a C-terminal sheep Fc-tag. The protein was purified from culture supernatant by Protein G affinity chromatography. |
| REC31798-500 | Yellow Fever virus Envelope protein, sheep Fc-tag | Recombinant Yellow Fever virus Envelope protein (NCBI accession number AWB15005, AA287-679) produced in insect cells. Protein contains a C-terminal sheep Fc-tag. The protein was purified from culture supernatant by Protein G affinity chromatography. |
| REC31652-500 | Hepatitis E ORF2 protein, mouse Fc-tag | Recombinant Hepatitis E (HEV) ORF2. Protein contains a C-terminal mouse Fc-tag. |
| REC31796-100 | Measles Virus Nucleoprotein (HEK293) | Recombinant Measles virus Nucleoprotein NP, produced in HEK293 cells. Protein was purified by fractionation of transiently transfected cells. |
| REC31796-500 | Measles Virus Nucleoprotein (HEK293) | Recombinant Measles virus Nucleoprotein NP, produced in HEK293 cells. Protein was purified by fractionation of transiently transfected cells. |
| REC31740-250 | Ebola Virus Envelope Glycoprotein (GP) (Zaire, Boende-Lokolia) | Recombinant Zaire ebola virus GP (NCBI AIO11753, AA1-637) was produced with a C-terminal His-tag. in HEK293 cells, and purified from culture supernatant by a series of immobilised metal affinity, ion exchange and size exclusion chromatography. |
| REC31741-100 | Ebola Virus Envelope Glycoprotein (GP1) (Zaire, Boende-Lokolia) | Recombinant Zaire ebola virus GP1 (NCBI AIO11753, AA1-501) was produced with a C-terminal His-tag. in HEK293 cells, and purified from culture supernatant by a series of immobilised metal affinity, ion exchange and size exclusion chromatography. |
| REC31740-100 | Ebola Virus Envelope Glycoprotein (GP) (Zaire, Boende-Lokolia) | Recombinant Zaire ebola virus GP (NCBI AIO11753, AA1-637) was produced with a C-terminal His-tag. in HEK293 cells, and purified from culture supernatant by a series of immobilised metal affinity, ion exchange and size exclusion chromatography. |
| REC31741-250 | Ebola Virus Envelope Glycoprotein (GP1) (Zaire, Boende-Lokolia) | Recombinant Zaire ebola virus GP1 (NCBI AIO11753, AA1-501) was produced with a C-terminal His-tag. in HEK293 cells, and purified from culture supernatant by a series of immobilised metal affinity, ion exchange and size exclusion chromatography. |
| NAT41585-100 | Toxocara Canis Antigen | Soluble native antigen fraction purified from Toxocara canis larvae. |
| REC31795-100 | Feline Immunodeficiency Virus Core Protein | Feline immunodeficiency virus core protein is a recombinant antigen produced in E. coli. |
| NAT41583-100 | Borrelia Afzelii Antigen | Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
| NAT41583-500 | Borrelia Afzelii Antigen | Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
| NAT41584-100 | Borrelia Garinii Antigen | Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
| REC31793-500 | Hantaan Virus Nucleoprotein (HEK293), His-tag | Recombinant Hantaan virus Nucleoprotein (NCBI accession number ACY79415.1, AA1-429), expressed in HEK293 cells. The protein contains a C-terminal 26 amino acid glycine-serine linker with an embedded TEV protease site followed by a 6x histidine tag. The pr |
| REC31793-100 | Hantaan Virus Nucleoprotein (HEK293), His-tag | Recombinant Hantaan virus Nucleoprotein (NCBI accession number ACY79415.1, AA1-429), expressed in HEK293 cells. The protein contains a C-terminal 26 amino acid glycine-serine linker with an embedded TEV protease site followed by a 6x histidine tag. The pr |
| NAT41584-500 | Borrelia Garinii Antigen | Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
| REC31781-100 | Dengue Virus Serotype 4 NS1 Protein (Insect Cells) | Recombinant Dengue virus serotype 4 NS1 recombinant protein is expressed in Baculovirus-infected insect cells and purified by proprietary affinity chromatography methodologies. |
| REC31779-100 | Dengue Virus Serotype 2 NS1 Protein (Insect Cells) | Recombinant Dengue virus serotype 2 NS1 recombinant protein is expressed in Baculovirus-infected insect cells and purified by proprietary affinity chromatography methodologies. |
| REC31778-100 | Dengue Virus Serotype 1 NS1 Protein (Insect Cells) | Recombinant Dengue virus serotype 1 NS1 recombinant protein is expressed in Baculovirus-infected insect cells and purified by proprietary affinity chromatography methodologies. |
| REC31780-100 | Dengue Virus Serotype 3 NS1 Protein (Insect Cells) | Recombinant Dengue virus serotype 3 NS1 recombinant protein is expressed in Baculovirus-infected insect cells and purified by proprietary affinity chromatography methodologies. |
| REC31788-100 | Canine Parvovirus 2 VP2 Capsid Protein | Recombinant canine parvovirus type 2b (CPV-2b) capsid protein VP2 is expressed in insect cells and consists of 584 amino acid residues. Theoretical molecular weight 64657 Da. Theoretical pI 5.36. Does not contain any affinity tags. |
| REC31775-100 | Zika Virus DIII Envelope Protein (Asian strain) | Recombinant Zika virus DIII envelope protein expressed in E.coli. |
| REC31762-100 | Dengue Virus Serotype 2 DIII envelope protein | Recombinant protein (11.5 kDa) manufactured in E. coli. Contains the Immunoglobulin-like domain DIII of Dengue virus serotype 2 (DENV2) envelope protein. Protein contains a His-tag and has an approximate pI of 6.7-7. |
| REC31763-100 | Dengue Virus Serotype 3 DIII envelope protein | Recombinant protein (11.5 kDa) manufactured in E. coli. Contains the Immunoglobulin-like domain DIII of Dengue virus serotype 3 (DENV3) envelope protein. |
| REC31761-100 | Dengue Virus Serotype 1 DIII envelope protein | Recombinant protein manufactured in E. coli. Contains the Immunoglobulin-like domain DIII of Dengue virus serotype 1 (DENV1) envelope protein. Protein contains a His-tag and has an approximate pI of 6.7-7. |
| REC31764-100 | Dengue Virus Serotype 4 DIII envelope protein | Recombinant protein (11.2 kDa) manufactured in E. coli. Contains the Immunoglobulin-like domain DIII of Dengue virus serotype 4 (DENV4) envelope protein. |
| NAT41582-100 | Leptospira Biflexa Antigen (Strain Patoc 1) | Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
| NAT41582-500 | Leptospira Biflexa Antigen (Strain Patoc 1) | Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
| NAT41581-500 | Tick-Borne Encephalitis Virus Lysate (Strain Moscow B-4) | Native Tick-Borne Encephalitis Virus lysate antigen produced in Vero cells. |
| REC31776-100 | Echovirus Antigen, Recombinant | Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
| REC31776-500 | Echovirus Antigen, Recombinant | Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
| NAT41581-100 | Tick-Borne Encephalitis Virus Lysate (Strain Moscow B-4) | Native Tick-Borne Encephalitis Virus lysate antigen produced in Vero cells. |
| REC31772-500 | Enterovirus Antigen, Recombinant | Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
| REC31772-100 | Enterovirus Antigen, Recombinant | Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
| REC31760-100 | MERS Coronavirus Spike Glycoprotein (S1), His-tag (E. coli) | A peptide from amino acids 56 to 295 of Spike protein S1 (Accession: AHC74088) was expressed and purified from E. coli, with a 6xHis tag is attached to its C-terminus. |
| REC31760-500 | MERS Coronavirus Spike Glycoprotein (S1), His-tag (E. coli) | A peptide from amino acids 56 to 295 of Spike protein S1 (Accession: AHC74088) was expressed and purified from E. coli, with a 6xHis tag is attached to its C-terminus. |
| EBOVKW95-ENV-250 | Ebola Virus Envelope Glycoprotein (GP) (Zaire, Kikwit-95) | Recombinant Ebolavirus EBOV (subtype Zaire,strain Kikwit-95) Envelope Glycoprotein (GP) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| REC31746-100 | Nipah virus Nucleoprotein (N), His-tag | Recombinant Nipah virus Nucleoprotein (N), expressed in mammalian HEK293 cells. Product has a C-terminal His-tag. |
| REC31746-500 | Nipah virus Nucleoprotein (N), His-tag | Recombinant Nipah virus Nucleoprotein (N), expressed in mammalian HEK293 cells. Product has a C-terminal His-tag. |
| REC31745-500 | African Swine Fever virus pp62 polyprotein, His-tag | Recombinant African Swine Fever virus (ASFV) pp62 polyprotein expressed in mammalian cells and purified from cell pellets by immobilised metal affinity and ion exchange chromatography. This polyprotein is the precursor for structural proteins p15 and p35. |
| REC31745-100 | African Swine Fever virus pp62 polyprotein, His-tag | Recombinant African Swine Fever virus (ASFV) pp62 polyprotein expressed in mammalian cells and purified from cell pellets by immobilised metal affinity and ion exchange chromatography. This polyprotein is the precursor for structural proteins p15 and p35. |
| REC31730-500 | Crimean-Congo Hemorrhagic Fever Virus Gc Protein, Sheep Fc-Tag | Crimean-Congo Haemorrhagic Fever virus (CCHFV) glycoprotein C (Gc) produced in HEK293 cells, and purified from culture supernatant. The C-terminal transmembrane domain and the intravirion tail of the protein have been replaced by a 15 amino acid glycine-s |
| REC31730-100 | Crimean-Congo Hemorrhagic Fever Virus Gc Protein, Sheep Fc-Tag | Crimean-Congo Haemorrhagic Fever virus (CCHFV) glycoprotein C (Gc) produced in HEK293 cells, and purified from culture supernatant. The C-terminal transmembrane domain and the intravirion tail of the protein have been replaced by a 15 amino acid glycine-s |
| REC31735-500 | Plasmodium falciparum HRP-II Protein | Plasmodium falciparum HRP-II protein expressed in E. coli. |
| REC31734-100 | Pan-Plasmodium Aldolase Protein | Pan-Plasmodium Aldolase protein expressed in E. coli. |
| REC31734-500 | Pan-Plasmodium Aldolase Protein | Pan-Plasmodium Aldolase protein expressed in E. coli. |
| REC31735-100 | Plasmodium falciparum HRP-II Protein | Plasmodium falciparum HRP-II protein expressed in E. coli. |
| REC31736-100 | Plasmodium vivax LDH Protein | Plasmodium vivax LDH protein expressed in E. coli. |
| REC31736-500 | Plasmodium vivax LDH Protein | Plasmodium vivax LDH protein expressed in E. coli. |
| REC31737-100 | Plasmodium falciparum LDH Protein | Plasmodium falciparum LDH protein expressed in E. coli. |
| REC31737-500 | Plasmodium falciparum LDH Protein | Plasmodium falciparum LDH protein expressed in E. coli. |
| REC31738-500 | Enterovirus CoxB3 VP1 Protein | Enterovirus CoxB3 recombinant VP1 protein with N-term GST tag. |
| REC31738-100 | Enterovirus CoxB3 VP1 Protein | Enterovirus CoxB3 recombinant VP1 protein with N-term GST tag. |
| NAT41579-100 | Recombinant Autographa Californica Multiple Nucleopolyhedrovirus, Lysate | Autographa Californica Multiple Nucleopolyhedrovirus lysate control, for testing baculovirus-insect cell derived antigens in assays. |
| NAT41579-500 | Recombinant Autographa Californica Multiple Nucleopolyhedrovirus, Lysate | Autographa Californica Multiple Nucleopolyhedrovirus lysate control, for testing baculovirus-insect cell derived antigens in assays. |
| REC31729-500 | Ebola Virus Nucleoprotein (NP) (Sudan) | Recombinant Ebolavirus NP (Sudan) C-term produced in E. coli. |
| REC31729-100 | Ebola Virus Nucleoprotein (NP) (Sudan) | Recombinant Ebolavirus NP (Sudan) C-term produced in E. coli. |
| REC31728-500 | Ebola Virus Nucleoprotein (NP) (Zaire) | Recombinant Ebolavirus NP (Zaire) C-term produced in E. coli. Protein is ~15 kDa and contains a C-terminal His-tag. |
| REC31728-100 | Ebola Virus Nucleoprotein (NP) (Zaire) | Recombinant Ebolavirus NP (Zaire) C-term produced in E. coli. Protein is ~15 kDa and contains a C-terminal His-tag. |
| REC31727-100 | Ebola Virus VP40 (Zaire) | Full length Ebola (Zaire) VP40 comprising 325 amino acids is expressed and purified from E. coli with a 6xHis tag is attached to its C terminus. |
| REC31727-500 | Ebola Virus VP40 (Zaire) | Full length Ebola (Zaire) VP40 comprising 325 amino acids is expressed and purified from E. coli with a 6xHis tag is attached to its C terminus. |
| REC31725-100 | Hantaan Virus Nucleoprotein (E. coli) | Hantavirus Nucleocapsid (N) protein produced in E. coli. |
| REC31724-100 | Plasmodium vivax MSP1 | Recombinant Plasmodium vivax MSP1 protein expressed in E. coli with GST-tag. |
| REC31725-500 | Hantaan Virus Nucleoprotein (E. coli) | Hantavirus Nucleocapsid (N) protein produced in E. coli. |
| REC31724-500 | Plasmodium vivax MSP1 | Recombinant Plasmodium vivax MSP1 protein expressed in E. coli with GST-tag. |
| REC31723-500 | Plasmodium falciparum MSP1 | Plasmodium falciparum MSP is expressed and purified from E. coli. The expressed MSP1 p36 contains a GST tag, and GST-MSP1 migrates at 36 kDa. Can be used with Plasmodium vivax MSP1 for ELISA and rapid test. |
| REC31723-100 | Plasmodium falciparum MSP1 | Plasmodium falciparum MSP is expressed and purified from E. coli. The expressed MSP1 p36 contains a GST tag, and GST-MSP1 migrates at 36 kDa. Can be used with Plasmodium vivax MSP1 for ELISA and rapid test. |
| NAT41580-100 | Legionella pneumophila antigen (native extract) | Inactivated Legionella pneumophila antigen from culture. |
| REC31722-500 | Norovirus GI.1 VLP | Recombinant Norovirus GI.1 VP1 Virus-Like Particles produced in baculovirus-infected insect cells. Norovirus VP1 structural protein is expressed to form a particle without the non-structural proteins or genome. Resultant particles are totally non-infectio |
| REC31722-100 | Norovirus GI.1 VLP | Recombinant Norovirus GI.1 VP1 Virus-Like Particles produced in baculovirus-infected insect cells. Norovirus VP1 structural protein is expressed to form a particle without the non-structural proteins or genome. Resultant particles are totally non-infectio |
| REC31721-500 | Lassa Fever Virus GP1 Protein (Sheep Fc) | Recombinant Lassa Fever Virus GP1 protein produced in 293 human cells. Protein contains a c-terminal Sheep-Fc-tag. |
| REC31721-100 | Lassa Fever Virus GP1 Protein (Sheep Fc) | Recombinant Lassa Fever Virus GP1 protein produced in 293 human cells. Protein contains a c-terminal Sheep-Fc-tag. |
| REC31719-100 | Human integrin alpha-5 beta-3, His-tag | Recombinant human integrin alpha-5 beta-3 protein produced in HEK293 with a C-terminal 6x histidine tag. |
| REC31719-500 | Human integrin alpha-5 beta-3, His-tag | Recombinant human integrin alpha-5 beta-3 protein produced in HEK293 with a C-terminal 6x histidine tag. |
| REC31717-50 | Human Immunodeficiency Virus Tat Protein[HIV-1/Clade D (UG28R)] | Recombinant HIV-1 Tat produced in E. coli. |
| REC31716-50 | Human Immunodeficiency Virus Tat Protein [HIV-1/Clade C (TV019)] | Recombinant HIV-1 Tat produced in E. coli. |
| REC31715-50 | Human Immunodeficiency Virus Tat Protein [HIV-1/Clade B (BH10)] | Recombinant HIV-1 TAT (transactivating regulatory protein) is produced in E.coli as a single, non-glycosylated, polypeptidic chain containing 86 amino acids encoded by two exons. |
| REC31714-50 | Human Immunodeficiency Virus Tat Protein [HIV-1/Clade A (UGMED5)] | Recombinant HIV-1 Tat produced in E. coli. |
| REC31712-500 | Human Immunodeficiency Virus Integrase Protein [HIV-1/Clade B (IIIB)] | Recombinant HIV-1 Integrase produced in E. coli and fused with with N-terminal GST. |
| REC31712-100 | Human Immunodeficiency Virus Integrase Protein [HIV-1/Clade B (IIIB)] | Recombinant HIV-1 Integrase produced in E. coli and fused with with N-terminal GST. |
| REC31713-500 | Human Immunodeficiency Virus Reverse Transcriptase Protein [HIV-1/Clade B (IIIB)] | Recombinant HIV-1 Reverse Transcriptase produced in E. coli and fused with N-terminal GST. |
| REC31713-100 | Human Immunodeficiency Virus Reverse Transcriptase Protein [HIV-1/Clade B (IIIB)] | Recombinant HIV-1 Reverse Transcriptase produced in E. coli and fused with N-terminal GST. |
| REC31709-100 | Human Immunodeficiency Virus GP41 Protein [HIV-1/Clade B] | Recombinant HIV-1 gp41 produced in E. coli with His-tag. |
| REC31710-500 | Human Immunodeficiency Virus GP41 Protein [HIV-1/Group O] | Recombinant HIV-1 gp41 produced in E. coli with His-tag. |
| REC31710-100 | Human Immunodeficiency Virus GP41 Protein [HIV-1/Group O] | Recombinant HIV-1 gp41 produced in E. coli with His-tag. |
| REC31709-500 | Human Immunodeficiency Virus GP41 Protein [HIV-1/Clade B] | Recombinant HIV-1 gp41 produced in E. coli with His-tag. |
| REC31708-100 | Human Immunodeficiency Virus GP41 Protein [HIV-1/Clade B (IIIB)] | Recombinant HIV-1 gp41 produced in E. coli and fused with ?-galactosidase. |
| REC31707-500 | Human Immunodeficiency Virus Nef Protein [HIV-1/Clade B (IIIB)] | Recombinant HIV-1 Nef produced in E. coli and fused with ?-galactosidase. |
| REC31707-100 | Human Immunodeficiency Virus Nef Protein [HIV-1/Clade B (IIIB)] | Recombinant HIV-1 Nef produced in E. coli and fused with ?-galactosidase. |
| REC31708-500 | Human Immunodeficiency Virus GP41 Protein [HIV-1/Clade B (IIIB)] | Recombinant HIV-1 gp41 produced in E. coli and fused with ?-galactosidase. |
| REC31706-500 | Human Immunodeficiency Virus P24 Protein [HIV-1/Clade C] | Recombinant HIV-1 p24 produced in E. coli with a 6x histidine tag. |
| REC31706-100 | Human Immunodeficiency Virus P24 Protein [HIV-1/Clade C] | Recombinant HIV-1 p24 produced in E. coli with a 6x histidine tag. |
| NAT41576-100 | Measles virus lysate | Purified Measles virus lysate. |
| NAT41577-100 | Mumps virus lysate (Isolate 1) | Mumps virus lysate (Isolate 1). |
| REC31704-500 | Japanese Encephalitis Virus VLP | Recombinant JEV VLPs composed of pre-Membrane and Envelope proteins expressed in HEK293 cells and purified from culture supernatant. |
| REC31704-100 | Japanese Encephalitis Virus VLP | Recombinant JEV VLPs composed of pre-Membrane and Envelope proteins expressed in HEK293 cells and purified from culture supernatant. |
| REC31705-100 | Recombinant human IgE (kappa L), His-tag | Recombinant human IgE is composed of the human ? heavy chain and the ? light chain. The antibody recognises Zika virus NS1. The heavy chain is C-terminally His-tag. |
| REC31705-500 | Recombinant human IgE (kappa L), His-tag | Recombinant human IgE is composed of the human ? heavy chain and the ? light chain. The antibody recognises Zika virus NS1. The heavy chain is C-terminally His-tag. |
| NAT41563-100 | Yellow Fever virus lysate, 17D strain | Purified yellow fever virus Lysate (17D strain). |
| NAT41561-100 | West Nile virus lysate | Purified West Nile virus Lysate (NY 2001-6263 strain). |
| REC31698-500 | Wesselsbron Virus NS1 protein | Recombinant Wesselsbron Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| REC31698-100 | Wesselsbron Virus NS1 protein | Recombinant Wesselsbron Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| REC31699-100 | Lassa Fever Virus GP2 Protein (Sheep Fc) | Recombinant Lassa Fever Virus GP2 protein produced in 293 human cells. Protein contains a c-terminal Sheep-Fc-tag. |
| REC31701-100 | Borrelia burgdorferi C(t) Protein | Recombinant Borrelia burgdorferi Ct (OspC terminal) antigen, produced in E. coli. |
| REC31700-100 | Borrelia burgdorferi C(p) Protein | Recombinant Borrelia burgdorferi Cp (OspC proximal) antigen, produced in E. coli. |
| REC31699-500 | Lassa Fever Virus GP2 Protein (Sheep Fc) | Recombinant Lassa Fever Virus GP2 protein produced in 293 human cells. Protein contains a c-terminal Sheep-Fc-tag. |
| REC31697-500 | Human DAG, Fc-Tag | Recombinant alpha-dystroglycan (DAG), produced in HEK293 cells and purified from culture supernatant. The C-terminal transmembrane domain and the cytoplasmic tail of the protein have been replaced by a 15 amino acid glycine-serine linker and the human IgG |
| REC31697-100 | Human DAG, Fc-Tag | Recombinant alpha-dystroglycan (DAG), produced in HEK293 cells and purified from culture supernatant. The C-terminal transmembrane domain and the cytoplasmic tail of the protein have been replaced by a 15 amino acid glycine-serine linker and the human IgG |
| REC31693-100 | Hepatitis C Virus Core Antigen (HCcAg) | Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag. |
| REC31692-1000 | Human Immunodeficiency Virus GP120 Protein [HIV-1/Clade B (89BZ_167)] | Recombinant HIV glycoprotein 120 (amino acids 31-511) produced in HEK293 cells. C-terminal transmembrane domain and the intravirion tail of the protein have been replaced by a 9 amino acid glycine-serine linker and a 6x histidine tag. |
| REC31694-100 | Human Immunodeficiency Virus GP120 Protein [HIV-1/Clade C (16055)] | Recombinant HIV glycoprotein 120 (amino acids 36-506) produced in HEK293 cells. C-terminal transmembrane domain and the intravirion tail of the protein have been replaced by a 9 amino acid glycine-serine linker and a 6x histidine tag. |
| REC31694-1000 | Human Immunodeficiency Virus GP120 Protein [HIV-1/Clade C (16055)] | Recombinant HIV glycoprotein 120 (amino acids 36-506) produced in HEK293 cells. C-terminal transmembrane domain and the intravirion tail of the protein have been replaced by a 9 amino acid glycine-serine linker and a 6x histidine tag. |
| REC31691-100 | Human Immunodeficiency Virus GP120 Protein [HIV-1/Clade A (KNH1144)] | Recombinant HIV glycoprotein 120 (amino acids 36-511) produced in HEK293 cells. C-terminal transmembrane domain and the intravirion tail of the protein have been replaced by a 9 amino acid glycine-serine linker and a 6x histidine tag. |
| REC31691-1000 | Human Immunodeficiency Virus GP120 Protein [HIV-1/Clade A (KNH1144)] | Recombinant HIV glycoprotein 120 (amino acids 36-511) produced in HEK293 cells. C-terminal transmembrane domain and the intravirion tail of the protein have been replaced by a 9 amino acid glycine-serine linker and a 6x histidine tag. |
| REC31695-100 | Human Immunodeficiency Virus GP120 Protein [HIV-1/Clade AE (CM240)] | Recombinant HIV glycoprotein 120 (amino acids 36-505) produced in HEK293 cells. C-terminal transmembrane domain and the intravirion tail of the protein have been replaced by a 9 amino acid glycine-serine linker and a 6x histidine tag. |
| REC31692-100 | Human Immunodeficiency Virus GP120 Protein [HIV-1/Clade B (89BZ_167)] | Recombinant HIV glycoprotein 120 (amino acids 31-511) produced in HEK293 cells. C-terminal transmembrane domain and the intravirion tail of the protein have been replaced by a 9 amino acid glycine-serine linker and a 6x histidine tag. |
| REC31693-500 | Hepatitis C Virus Core Antigen (HCcAg) | Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag. |
| REC31695-1000 | Human Immunodeficiency Virus GP120 Protein [HIV-1/Clade AE (CM240)] | Recombinant HIV glycoprotein 120 (amino acids 36-505) produced in HEK293 cells. C-terminal transmembrane domain and the intravirion tail of the protein have been replaced by a 9 amino acid glycine-serine linker and a 6x histidine tag. |
| NAT41557-100 | Chikungunya virus lysate | Purified Chikungunya virus lysate. |
| REC31696-100 | Crimean-Congo Haemorrhagic Fever virus (CCHFV) glycoprotein C (Gc), human Fc-tag | Recombinant Crimean Congo Hemorraghic Fever Virus Gc protein produced in HEK293 cells, and purified from culture supernatant. The C-terminal transmembrane domain and the intravirion tail of the protein have been replaced by a 15 amino acid glycine-serine |
| REC31696-500 | Crimean-Congo Haemorrhagic Fever virus (CCHFV) glycoprotein C (Gc), human Fc-tag | Recombinant Crimean Congo Hemorraghic Fever Virus Gc protein produced in HEK293 cells, and purified from culture supernatant. The C-terminal transmembrane domain and the intravirion tail of the protein have been replaced by a 15 amino acid glycine-serine |
| REC31657-500 | Puumala Virus Glycoprotein 1 (Gn), Human Fc-tag | Recombinant Puumala virus, glycoprotein 1 (aa 1-496). Protein contains a human Fc-tag. |
| REC31657-100 | Puumala Virus Glycoprotein 1 (Gn), Human Fc-tag | Recombinant Puumala virus, glycoprotein 1 (aa 1-496). Protein contains a human Fc-tag. |
| AD002-100 | Adenovirus Type 5 Particles, CMV-β-galatosidase | Ad5 with an E1 and E3 deletion. Insertion of CMV-driven nuclear-targeted β-galatosidase gene in E1 region. Concentrated and purified virus particles from a double CsCl gradient purification with DNase treatment and dialysis. Safety category BSL1. |
| AD001-100 | Adenovirus Type 5 Particles, CMV-Luciferase | Ad5 with an E1 and E3 deletion. Insertion of CMV-driven Luciferase gene in E1 region. Concentrated and purified virus particles from a double CsCl gradient purification with DNase tr Product Description Ad5 with an E1 and E3 deletion. Insert |
| AD003-100 | Adenovirus Type 5 Particles, CMV-GFP | Ad5 with an E1 and E3 deletion. Insertion of CMV-driven GFP gene in E1 region. Concentrated and purified virus particles from a double CsCl gradient purification with DNase treatment and dialysis. Safety category BSL1. |
| AD004-100 | Adenovirus Type 3 Particles, Wild-type | Wild type Adenovirus type 3. Concentrated and purified virus particles from a double CsCl gradient purification with DNase treatment and dialysis. Safety category BSL2. |
| AD005-100 | Adenovirus Type 5 Particles, Wild-type | Concentrated and purified wild type Adenovirus type 5 particles. |
| AD006-100 | Adenovirus Type 11 Particles, Wild-type | Wild type Adenovirus type 11. Concentrated and purified virus particles from a double CsCl gradient purification with DNase treatment and dialysis. Safety category BSL2. |
| FLUH7N9-HAFC-1000 | Influenza A [A/Shanghai/2/2013 (H7N9)] Hemagglutinin (HA), Fc-tag | Recombinant Influenza A Hemagglutinin (HA) contains amino acids Asp19 – Gly338, Leu341 – Asp523 and was produced in human 293 cells (HEK293) with a human IgG1 Fc-tag at the C-terminus. |
| FLUH9N2-HA1-100 | Influenza A [A/Guinea fowl/Hong Kong/WF10/1999 (H9N2)] Hemagglutinin 1(HA1), His-tag | Recombinant Influenza A [A/Guinea fowl/Hong Kong/WF10/99 (H9N2)] Hemagglutinin 1(HA1) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| VeZIKV-LYS-100 | Zika Virus Vero Cell Lysate | Lysate of Zika virus infected Vero cells. |
| FLUH9N2-HA1-1000 | Influenza A [A/Guinea fowl/Hong Kong/WF10/1999 (H9N2)] Hemagglutinin 1(HA1), His-tag | Recombinant Influenza A [A/Guinea fowl/Hong Kong/WF10/99 (H9N2)] Hemagglutinin 1(HA1) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| FLUH7N9-HA-1000 | Influenza A [A/Shanghai/2/2013(H7N9)] Hemagglutinin (HA), His-tag | Recombinant Influenza A [A/Shanghai/2/2013(H7N9)] Hemagglutinin (HA) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| FLUH7N9-HA-100 | Influenza A [A/Shanghai/2/2013(H7N9)] Hemagglutinin (HA), His-tag | Recombinant Influenza A [A/Shanghai/2/2013(H7N9)] Hemagglutinin (HA) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| FLUH7N9-HAFC-100 | Influenza A [A/Shanghai/2/2013 (H7N9)] Hemagglutinin (HA), Fc-tag | Recombinant Influenza A Hemagglutinin (HA) contains amino acids Asp19 – Gly338, Leu341 – Asp523 and was produced in human 293 cells (HEK293) with a human IgG1 Fc-tag at the C-terminus. |
| HS105-1000 | Herpes Simplex Virus 1 Antigen | HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
| REC31689-500 | Hepatitis B Virus Core Antigen (HBcAg) | Recombinant Hepititis B Virus Core Protein (HBcAg). |
| ZIKVSU-NS1-500 | Zika Virus NS1 Protein (Suriname Strain) | Recombinant Zika Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. The oligomerisation state is predominantly hexameric. |
| JEV-NS1-500 | Japanese Encephalitis Virus NS1 Protein | Recombinant Japanese encephalitis virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. and is presented in 2 distinct oligomeric states with molecular weights of 335 kDa and 450 kDa, as determined by size exclusion chrom |
| JEV-NS1-100 | Japanese Encephalitis Virus NS1 Protein | Recombinant Japanese encephalitis virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. and is presented in 2 distinct oligomeric states with molecular weights of 335 kDa and 450 kDa, as determined by size exclusion chrom |
| HS205-200 | Herpes Simplex Virus 2 Antigen | HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
| HS205-1000 | Herpes Simplex Virus 2 Antigen | HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
| ZIKV-LYS-500 | Purified Zika Virus Lysate | Purified Zika Virus lysate. |
| HS105-200 | Herpes Simplex Virus 1 Antigen | HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
| HIV-CM244-GP120-100 | Human Immunodeficiency Virus GP120 Protein [HIV-1/Clade E (CM244)] | Recombinant HIV-1 (CM244) GP120 protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| ZIKV-NS1-500 | Zika Virus NS1 Protein (Uganda strain) | Recombinant Zika Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| ZIKV-NS1-100 | Zika Virus NS1 Protein (Uganda strain) | Recombinant Zika Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| HS104-1000 | Herpes Simplex Virus 1 Lysate Antigen | A high concentration of HSV-1 particles and proteins from a clarified cell lysate. |
| EBOVUG2007-SGP-1000 | Ebola Virus Secreted Glycoprotein (sGP) (Bundibugyo) | Recombinant Ebolavirus BDBV(subtype Bundibugyo,strain Uganda 2007) Small/secreted Glycoprotein (sGP) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| HIV-CM244-GP120-1000 | Human Immunodeficiency Virus GP120 Protein [HIV-1/Clade E (CM244)] | Recombinant HIV-1 (CM244) GP120 protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| VeZIKV-LYS-500 | Zika Virus Vero Cell Lysate | Lysate of Zika virus infected Vero cells. |
| HS204-1000 | Herpes Simplex Virus 2 Lysate Antigen | A high concentration of HSV-2 particles and proteins from a clarified cell lysate. |
| VAC-B18R-500 | Vaccinia Virus B18R | Vaccinia Virus B18R Protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| CDB-TNL-500 | Clostridium Difficile Toxin B | Native toxin B purified from C. difficile. |
| CDB-TNL-50 | Clostridium Difficile Toxin B | Native toxin B purified from C. difficile. |
| CDB-TNL-100 | Clostridium Difficile Toxin B | Native toxin B purified from C. difficile. |
| REC31824-100 | African Swine Fever Virus P72 Protein, His-tag (E. coli) | Recombinant African Swine Fever virus (ASFV) p72 antigen, comprising amino acids 40-315, manufactured in E. coli with a His-tag. |
| REC31824-500 | African Swine Fever Virus P72 Protein, His-tag (E. coli) | Recombinant African Swine Fever virus (ASFV) p72 antigen, comprising amino acids 40-315, manufactured in E. coli with a His-tag. |
| AS02-200 | Astrovirus Antigen (Type 1) | A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
| AS02-1000 | Astrovirus Antigen (Type 1) | A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
| RSV-GPB-1000 | Respiratory Syncytial Virus A Glycoprotein G (RSV A gG) | Recombinant HRSV (A) glycoprotein G protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| RSV-GPB-50 | Respiratory Syncytial Virus A Glycoprotein G (RSV A gG) | Recombinant HRSV (A) glycoprotein G protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| ZIKVDUO-NS1-100 | Zika Virus NS1 Proteins (Uganda/Suriname Strains Duo Pack) | Recombinant Zika Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| TBEV-NS1 | Tick-Borne Encephalitis Virus NS1 Protein | Recombinant Tick-Borne Encephalitis Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| REC31689-100 | Hepatitis B Virus Core Antigen (HBcAg) | Recombinant Hepititis B Virus Core Protein (HBcAg). |
| FLAVX4-NS1-100 | Flavivirus NS1 Protein Pack | Recombinant Flavivirus NS1 protein hexamer produced in 293 human cells. Protein contains a C-terminal His-tag.. Pack of 100ug from YFV, JEV, TBEV and WNV. |
| VAC-B18R-50 | Vaccinia Virus B18R | Vaccinia Virus B18R Protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| FLUH5N1-HA-1000 | Influenza A [A/Hong Kong/483/1997 (H5N1)] Hemagglutinin (HA), His-tag | Recombinant Influenza A [A/Hong Kong/483/97 (H5N1)] Hemagglutinin (HA) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| DENVX4-NS1-100 | Dengue Virus NS1 Protein Serotypes 1-4 | Recombinant Dengue Virus NS1 protein hexamer produced in 293 human cells. Protein contains a C-terminal His-tag.. Pack of all 4 serotypes. |
| DENVX4-NS1-500 | Dengue Virus NS1 Protein Serotypes 1-4 | Recombinant Dengue Virus NS1 protein hexamer produced in 293 human cells. Protein contains a C-terminal His-tag.. Pack of all 4 serotypes. |
| DENVX4VLP-100 | Dengue Virus VLP - Serotypes 1-4 | Recombinant Dengue Virus VLPs produced in mammalian cells. Pack of all 4 serotypes. |
| EBOVKW95-ENV-100 | Ebola Virus Envelope Glycoprotein (GP) (Zaire, Kikwit-95) | Recombinant Ebolavirus EBOV (subtype Zaire,strain Kikwit-95) Envelope Glycoprotein (GP) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| EBOVKW95-ENV-1000 | Ebola Virus Envelope Glycoprotein (GP) (Zaire, Kikwit-95) | Recombinant Ebolavirus EBOV (subtype Zaire,strain Kikwit-95) Envelope Glycoprotein (GP) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| EBOVKW95-GP1-100 | Ebola Virus Envelope Glycoprotein (GP1) (Zaire, Kikwit-95) | Recombinant Ebolavirus EBOV (subtype Zaire,strain Kikwit-95) Envelope Glycoprotein 1 (GP1) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| EBOVKW95-GP1-1000 | Ebola Virus Envelope Glycoprotein (GP1) (Zaire, Kikwit-95) | Recombinant Ebolavirus EBOV (subtype Zaire,strain Kikwit-95) Envelope Glycoprotein 1 (GP1) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| EBOVUG2007-GP1-100 | Ebola Virus Envelope Glycoprotein (GP1) (Bundibugyo) | Recombinant Ebolavirus (subtype Bundibugyo,strain Uganda 2007) Envelope Glycoprotein 1 (GP1) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| EBOVUG2007-GP1-1000 | Ebola Virus Envelope Glycoprotein (GP1) (Bundibugyo) | Recombinant Ebolavirus (subtype Bundibugyo,strain Uganda 2007) Envelope Glycoprotein 1 (GP1) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| CT022-1000 | Chlamydia Trachomatis Antigen | Chlamydia trachomatis antigens from clarified cell lysate. |
| EBOVUG2007-SGP-50 | Ebola Virus Secreted Glycoprotein (sGP) (Bundibugyo) | Recombinant Ebolavirus BDBV(subtype Bundibugyo,strain Uganda 2007) Small/secreted Glycoprotein (sGP) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| FLAVX4-NS1-500 | Flavivirus NS1 Protein Pack | Recombinant Flavivirus NS1 protein hexamer produced in 293 human cells. Protein contains a C-terminal His-tag.. Pack of 100ug from YFV, JEV, TBEV and WNV. |
| FLUH5N1-HA-100 | Influenza A [A/Hong Kong/483/1997 (H5N1)] Hemagglutinin (HA), His-tag | Recombinant Influenza A [A/Hong Kong/483/97 (H5N1)] Hemagglutinin (HA) protein produced in HEK293 cells. Protein contains a C-terminal His-tag. |
| TV01-1000 | Trichomonas Vaginalis Antigen | Washed & lysed suspension of whole protozoa |
| REC31633-500 | Nipah Virus Glycoprotein F, Human Fc-Tag | Recombinant Nipah virus glycoprotein F expressed in mammalian HEK293 cells. Product has a C-terminal human Fc-tag. |
| YFV-NS1 | Yellow Fever Virus NS1 Protein | Recombinant Yellow Fever Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| REC31619-500 | Oropouche Virus Gc Protein, Human Fc | Recombinant oropouche virus minor glycoprotein Gc expressed in HEK293 cells. Protein contains a C-terminal human Fc-tag. |
| PT-TNL-250 | Bordetella Pertussis Toxin | Purified native pertussis toxin from Bordetella pertussis, lyophilised for ease of storage, CHO cluster assay tested. |
| PT-TNL-100 | Bordetella Pertussis Toxin | Purified native pertussis toxin from Bordetella pertussis, lyophilised for ease of storage, CHO cluster assay tested. |
| REC31620-1000 | Norovirus GII.4 VLP | Recombinant Norovirus GII.4 VP1 Virus-Like Particles produced in 293 human cells. Norovirus VP1 structural protein is transiently expressed to form a particle without the non-structural proteins or genome. Resultant particles are totally non-infectious. |
| REC31625-100 | Dengue Virus Serotype 3 Envelope Protein (HEK293) | Recombinant Dengue virus serotype 3 envelope protein expressed in HEK293 mammalian cells, with C terminal His-tag. |
| REC31625-500 | Dengue Virus Serotype 3 Envelope Protein (HEK293) | Recombinant Dengue virus serotype 3 envelope protein expressed in HEK293 mammalian cells, with C terminal His-tag. |
| REC31628-100 | Mayaro Virus E2 Envelope Protein, Mouse Fc-tag | Recombinant Mayaro virus E2 protein. Protein contains a mouse Fc-tag. |
| NG01-1000 | Neisseria Gonorrhoeae Antigen | Homogenised lysate of pure bacteria. |
| REC31628-500 | Mayaro Virus E2 Envelope Protein, Mouse Fc-tag | Recombinant Mayaro virus E2 protein. Protein contains a mouse Fc-tag. |
| REC31629-100 | Mayaro Virus E2 Envelope Protein, Human Fc-tag | Recombinant Mayaro virus E2 protein. Protein contains a human Fc-tag. |
| PV-VP2-100 | Parvovirus VP2 Recombinant Protein | Recombinant parvovirus VP2 protein expressed in HEK293 mammalian cells. |
| REC31633-100 | Nipah Virus Glycoprotein F, Human Fc-Tag | Recombinant Nipah virus glycoprotein F expressed in mammalian HEK293 cells. Product has a C-terminal human Fc-tag. |
| PV-VP2-2000 | Parvovirus VP2 Recombinant Protein | Recombinant parvovirus VP2 protein expressed in HEK293 mammalian cells. |
| REC31634-100 | Toscana Virus Glycoprotein 2 (Gc), Human Heterodimeric Fc-tag | Recombinant Toscana Virus, glycoprotein 2 (G2), exodomain. Protein contains a human heterodimeric Fc-tag. |
| REC31634-500 | Toscana Virus Glycoprotein 2 (Gc), Human Heterodimeric Fc-tag | Recombinant Toscana Virus, glycoprotein 2 (G2), exodomain. Protein contains a human heterodimeric Fc-tag. |
| REC31636-100 | Dengue Virus Serotype 3 Envelope Protein, Human Fc-Tag (HEK293) | Recombinant Dengue virus serotype 3 envelope protein exodomain. Protein contains a human Fc-tag. |
| REC31636-500 | Dengue Virus Serotype 3 Envelope Protein, Human Fc-Tag (HEK293) | Recombinant Dengue virus serotype 3 envelope protein exodomain. Protein contains a human Fc-tag. |
| REC31640-100 | Rift Valley Fever Virus Nucleoprotein | Recombinant Rift Valley Fever Virus Nucleoprotein expressed in HEK293 cells. Protein contains an N-terminal His-tag. |
| REC31640-500 | Rift Valley Fever Virus Nucleoprotein | Recombinant Rift Valley Fever Virus Nucleoprotein expressed in HEK293 cells. Protein contains an N-terminal His-tag. |
| REC31641-100 | Lassa Fever Virus GP1 Protein (Mouse Fc) | Recombinant Lassa Fever Virus GP1 protein produced in 293 human cells. Protein contains a c-terminal Mouse-Fc-tag. |
| REC31641-500 | Lassa Fever Virus GP1 Protein (Mouse Fc) | Recombinant Lassa Fever Virus GP1 protein produced in 293 human cells. Protein contains a c-terminal Mouse-Fc-tag. |
| REC31642-100 | Lassa Fever Virus GP2 Protein (Mouse Fc) | Recombinant Lassa Fever Virus GP2 protein produced in 293 human cells. Protein contains a c-terminal Mouse-Fc-tag. |
| REC31642-500 | Lassa Fever Virus GP2 Protein (Mouse Fc) | Recombinant Lassa Fever Virus GP2 protein produced in 293 human cells. Protein contains a c-terminal Mouse-Fc-tag. |
| REC31644-100 | Mayaro Virus E2 Envelope Protein | Recombinant Mayaro virus E2 protein. Protein contains a C-terminal His-tag. |
| REC31644-500 | Mayaro Virus E2 Envelope Protein | Recombinant Mayaro virus E2 protein. Protein contains a C-terminal His-tag. |
| REC31629-500 | Mayaro Virus E2 Envelope Protein, Human Fc-tag | Recombinant Mayaro virus E2 protein. Protein contains a human Fc-tag. |
| REC31601-500 | Epstein Barr Virus gp125, Mouse Fc | Recombinant Epstein Barr virus gp125 protein produced in HEK293 cells. Protein contains a mouse Fc-tag. |
| REC31612-100 | Cytomegalovirus Glycoprotein B (gB) - Mouse Fc | Recombinant HCMV glycoprotein B (gB) protein produced in HEK293 cells. Protein has a mouse Fc-tag at the C-term. |
| REC31611-500 | Oropouche Virus Gn Protein, Human Fc | Recombinant oropouche virus minor glycoprotein Gn expressed in HEK293 cells. Protein contains a C-terminal human Fc-tag. |
| REC31611-100 | Oropouche Virus Gn Protein, Human Fc | Recombinant oropouche virus minor glycoprotein Gn expressed in HEK293 cells. Protein contains a C-terminal human Fc-tag. |
| REC31610-500 | Oropouche Virus Gn Protein, Mouse Fc | Recombinant oropouche virus minor glycoprotein Gn expressed in HEK293 cells. Protein contains a C-terminal mouse Fc-tag. |
| REC31610-100 | Oropouche Virus Gn Protein, Mouse Fc | Recombinant oropouche virus minor glycoprotein Gn expressed in HEK293 cells. Protein contains a C-terminal mouse Fc-tag. |
| REC31609-500 | Lassa Fever Virus GP1 Protein (Human Fc) | Recombinant Lassa Fever Virus GP1 protein produced in 293 human cells. Protein contains a c-terminal Human-Fc-tag. |
| REC31609-100 | Lassa Fever Virus GP1 Protein (Human Fc) | Recombinant Lassa Fever Virus GP1 protein produced in 293 human cells. Protein contains a c-terminal Human-Fc-tag. |
| REC31614-100 | West Nile Virus Envelope Protein | Recombinant West Nile Virus Envelope protein produced in HEK293 human cells. Product contains a C-terminal His-tag. |
| REC31614-500 | West Nile Virus Envelope Protein | Recombinant West Nile Virus Envelope protein produced in HEK293 human cells. Product contains a C-terminal His-tag. |
| REC31615-100 | Crimean Congo Hemorrhagic Fever Virus Gn Protein | Recombinant Crimean Congo Hemorraghic Fever Virus Gn protein expressed in HEK293 cells. |
| REC31615-500 | Crimean Congo Hemorrhagic Fever Virus Gn Protein | Recombinant Crimean Congo Hemorraghic Fever Virus Gn protein expressed in HEK293 cells. |
| REC31619-100 | Oropouche Virus Gc Protein, Human Fc | Recombinant oropouche virus minor glycoprotein Gc expressed in HEK293 cells. Protein contains a C-terminal human Fc-tag. |
| REC31602-100 | Epstein Barr Virus gp125, Human Fc | Recombinant Epstein Barr virus gp125 protein produced in HEK293 cells. Product has a Human Fc-tag. |
| REC31646-100 | Respiratory Syncytial Virus A Glycoprotein G, Human Fc-tag | Recombinant Respiratoy Syncytial virus (RSV), glycoprotein G (gG). Protein contains a human Fc-tag. |
| REC31601-100 | Epstein Barr Virus gp125, Mouse Fc | Recombinant Epstein Barr virus gp125 protein produced in HEK293 cells. Protein contains a mouse Fc-tag. |
| REC31600-500 | Oropouche Virus Nucleoprotein | Recombinant oropouche virus nucleoprotein expressed in E. coli. |
| REC31600-100 | Oropouche Virus Nucleoprotein | Recombinant oropouche virus nucleoprotein expressed in E. coli. |
| REC31616-100 | Mayaro Virus VLP | Recombinant Mayaro Virus-Like Particles produced in 293 human cells. Mayaro structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles are tota |
| R78-TNB-10 | Clostridium Difficile Toxin B Ribotype 078 | Native toxin B purified from hypervirulent C. difficile strain 210708 ribotype 078. |
| R78-TNA-2 | Clostridium Difficile Toxin A Ribotype 078 | Native toxin A purified from hypervirulent C. difficile strain 210708 ribotype 078. |
| R78-TNA-10 | Clostridium Difficile Toxin A Ribotype 078 | Native toxin A purified from hypervirulent C. difficile strain 210708 ribotype 078. |
| REC31616-25 | Mayaro Virus VLP | Recombinant Mayaro Virus-Like Particles produced in 293 human cells. Mayaro structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles are total |
| REC31616-500 | Mayaro Virus VLP | Recombinant Mayaro Virus-Like Particles produced in 293 human cells. Mayaro structural proteins are transiently expressed to form a particle comprising E1, E2 and capsid protein, without the non-structural proteins or genome. Resultant particles are total |
| R27-TNA-2 | Clostridium Difficile Toxin A Ribotype 027 | Native toxin A purified from hypervirulent C. difficile strain R20291 (Stoke Mandeville) ribotype 027. |
| R27-TNA-10 | Clostridium Difficile Toxin A Ribotype 027 | Native toxin A purified from hypervirulent C. difficile strain R20291 (Stoke Mandeville) ribotype 027. |
| PV-VP2-500 | Parvovirus VP2 Recombinant Protein | Recombinant parvovirus VP2 protein expressed in HEK293 mammalian cells. |
| REC31602-500 | Epstein Barr Virus gp125, Human Fc | Recombinant Epstein Barr virus gp125 protein produced in HEK293 cells. Product has a Human Fc-tag. |
| REC31685-1000 | Human Ephrin-B2 (EFNB2), His-tag | Recombinant EFNB2 protein (exodomain) produced in HEK293 cells, and purified from culture supernatant. Protein contains an C-terminal His-tag. |
| REC31678-100 | Saint Louis Encephalitis Virus NS1 Protein | Recombinant St. Louis Encephalitis virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| REC31678-500 | Saint Louis Encephalitis Virus NS1 Protein | Recombinant St. Louis Encephalitis virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| REC31679-100 | Dengue Virus Serotype 1 Envelope Protein (Insect Cells) | Recombinant Dengue virus Serotype 1 Envelope protein produced in insect cells (Baculovirus). |
| REC31679-500 | Dengue Virus Serotype 1 Envelope Protein (Insect Cells) | Recombinant Dengue virus Serotype 1 Envelope protein produced in insect cells (Baculovirus). |
| REC31681-100 | Dengue Virus Serotype 3 Envelope Protein (Insect Cells) | Recombinant Dengue virus Serotype 3 Envelope protein produced in insect cells (Baculovirus). |
| REC31681-500 | Dengue Virus Serotype 3 Envelope Protein (Insect Cells) | Recombinant Dengue virus Serotype 3 Envelope protein produced in insect cells (Baculovirus). |
| REC31682-100 | Dengue Virus Serotype 4 Envelope Protein (Insect Cells) | Recombinant Dengue Virus Serotype 4 Envelope Protein (DENV E), strain Philippines/H241, full-sequence expressed in insect cells (Baculovirus). Purified by proprietary affinity chromatography methodologies. |
| REC31682-500 | Dengue Virus Serotype 4 Envelope Protein (Insect Cells) | Recombinant Dengue Virus Serotype 4 Envelope Protein (DENV E), strain Philippines/H241, full-sequence expressed in insect cells (Baculovirus). Purified by proprietary affinity chromatography methodologies. |
| REC31683-100 | Human MOG, His-tag | Recombinant human Myelin-oligodendrocyte glycoprotein (MOG) protein (exodomain), produced in HEK293 cells and purified from culture supernatant. Protein contains a C-terminal His-tag. |
| REC31683-500 | Human MOG, His-tag | Recombinant human Myelin-oligodendrocyte glycoprotein (MOG) protein (exodomain), produced in HEK293 cells and purified from culture supernatant. Protein contains a C-terminal His-tag. |
| REC31684-100 | Human DC-SIGN, His-tag | Recombinant DC-SIGN protein (exodomain) produced in HEK293 cells, and purified from culture supernatant. Protein contains an N-terminal His-tag. |
| REC31645-100 | Respiratory Syncytial Virus A Glycoprotein G, Mouse Fc-tag | Recombinant Respiratoy Syncytial virus (RSV), glycoprotein G (gG). Protein contains a mouse Fc-tag. |
| REC31685-100 | Human Ephrin-B2 (EFNB2), His-tag | Recombinant EFNB2 protein (exodomain) produced in HEK293 cells, and purified from culture supernatant. Protein contains an C-terminal His-tag. |
| REC31676-500 | Human Neuropilin-2 (NRP-2), His-tag | Recombinant human neuropilin-2 (amino acids 23-864), expressed in human embryonic kidney (HEK) 293 cells and purified from culture supernatant. The cytoplasmic tail and the transmembrane region were replaced by a 9 amino acid glycine-serine linker follow |
| NAT41567-100 | Zika Virus Lysate PRVABC59 strain | Purified Zika Virus lysate (PRVABC59). |
| NAT41552-1000 | Adenovirus Type 40 Hexon Protein | Purified hexon protein. Hexon is the major Adenovirus capsid protein. It is present as 240 copies which form 20 facets of the icosahedral capsid. |
| NAT41552-100 | Adenovirus Type 40 Hexon Protein | Purified hexon protein. Hexon is the major Adenovirus capsid protein. It is present as 240 copies which form 20 facets of the icosahedral capsid. |
| REC31685-500 | Human Ephrin-B2 (EFNB2), His-tag | Recombinant EFNB2 protein (exodomain) produced in HEK293 cells, and purified from culture supernatant. Protein contains an C-terminal His-tag. |
| REC31686-100 | Human CLEC4M (L-SIGN), His-tag | Recombinant CLEC4M protein (exodomain) produced in HEK293 cells, and purified from culture supernatant. Protein contains an N-terminal His-tag. |
| ZIKV-LYS-250 | Purified Zika Virus Lysate | Purified Zika Virus lysate. |
| ZIKV-LYS-100 | Purified Zika Virus Lysate | Purified Zika Virus lysate. |
| ZIKVDUO-NS1-500 | Zika Virus NS1 Proteins (Uganda/Suriname Strains Duo Pack) | Recombinant Zika Virus NS1 protein produced in 293 human cells. Protein contains a C-terminal His-tag. |
| REC31612-500 | Cytomegalovirus Glycoprotein B (gB) - Mouse Fc | Recombinant HCMV glycoprotein B (gB) protein produced in HEK293 cells. Protein has a mouse Fc-tag at the C-term. |
| ZEBO-VLP | Ebola Virus-Like Particles | Recombinant Ebola virus like particles expressing nucleoprotein, glycoprotein and matrix protein, produced in 293 human cells. |
| REC31686-500 | Human CLEC4M (L-SIGN), His-tag | Recombinant CLEC4M protein (exodomain) produced in HEK293 cells, and purified from culture supernatant. Protein contains an N-terminal His-tag. |
| REC31687-100 | Human AXL, His-tag | Recombinant AXL protein (exodomain) produced in HEK293 cells, and purified from culture supernatant. Protein contains a C-terminal His-tag. |
| REC31684-500 | Human DC-SIGN, His-tag | Recombinant DC-SIGN protein (exodomain) produced in HEK293 cells, and purified from culture supernatant. Protein contains an N-terminal His-tag. |
| REC31658-100 | Borrelia burgdorferi sensu stricto (B31) CRASP-1 Protein | Recombinant Borrelia burgdorferi CRASP-1, MBP-tag. |
| REC31687-500 | Human AXL, His-tag | Recombinant AXL protein (exodomain) produced in HEK293 cells, and purified from culture supernatant. Protein contains a C-terminal His-tag. |
| REC31646-500 | Respiratory Syncytial Virus A Glycoprotein G, Human Fc-tag | Recombinant Respiratoy Syncytial virus (RSV), glycoprotein G (gG). Protein contains a human Fc-tag. |
| REC31647-100 | Puumala Virus Glycoprotein 2 (Gc), Human Heterodimeric Fc-tag | Recombinant Puumala virus, glycoprotein 2 (aa 660-1116). Protein contains a human heterodimeric Fc-tag |
| REC31647-500 | Puumala Virus Glycoprotein 2 (Gc), Human Heterodimeric Fc-tag | Recombinant Puumala virus, glycoprotein 2 (aa 660-1116). Protein contains a human heterodimeric Fc-tag |
| REC31648-100 | Human MXRA8, His-tag | Recombinant human MXRA8 protein, exodomain. Protein contains a C-terminal His-tag. |
| REC31648-500 | MXRA8 protein, human | Recombinant human MXRA8 protein, exodomain. Protein contains a C-terminal His-tag. |
| REC31650-100 | Dengue Virus Serotype 3 Envelope Protein, Mouse Fc-Tag (HEK293) | Recombinant Dengue virus serotype 3 envelope protein exodomain. Protein contains a mouse Fc-tag. |
| REC31650-500 | Dengue Virus Serotype 3 Envelope Protein, Mouse Fc-Tag (HEK293) | Recombinant Dengue virus serotype 3 envelope protein exodomain. Protein contains a mouse Fc-tag. |
| REC31652-100 | Hepatitis E Virus Capsid Protein (ORF2), Mouse Fc-Tag | Recombinant Hepatitis E (HEV) ORF2. Protein contains a C-terminal mouse Fc-tag. |
| REC31653-100 | Hepatitis E Virus Capsid Protein (ORF2), His-tag | Recombinant Hepatitis E (HEV) ORF2. Protein contains a C-terminal His-tag. |
| REC31653-500 | Hepatitis E Virus Capsid Protein (ORF2), His-tag | Recombinant Hepatitis E (HEV) ORF2. Protein contains a C-terminal His-tag. |
| REC31654-100 | Severe Fever with Thrombocytopenia Syndrome Virus Nucleoprotein | Recombinant Severe Fever with Thrombocytopenia Virus Nucleoprotein produced in HEK293 cells, with an N-terminal His-tag. |
| REC31677-500 | Hepatitis B Virus E Antigen (HBeAg) | Recombinant Hepititis B Virus E Protein (HBeAg). |
| REC31654-500 | Severe Fever with Thrombocytopenia Syndrome Virus Nucleoprotein | Recombinant Severe Fever with Thrombocytopenia Virus Nucleoprotein produced in HEK293 cells, with an N-terminal His-tag. |
| REC31677-100 | Hepatitis B Virus E Antigen (HBeAg) | Recombinant Hepititis B Virus E Protein (HBeAg). |
| REC31659-100 | Borrelia burgdorferi sensu stricto (B31) CRASP-2 Protein | Recombinant Borrelia burgdorferi CRASP-2, MBP-tag. |
| REC31660-100 | Borrelia burgdorferi sensu stricto (B31) DbpA Protein | Recombinant Borrelia burgdorferi DbpA, MBP-tag. |
| REC31661-100 | Borrelia burgdorferi sensu stricto (B31) DbpB Protein | Recombinant Borrelia burgdorferi DbpB, MBP-tag. |
| REC31664-100 | Borrelia burgdorferi sensu stricto (B31) OspB Protein | Recombinant Borrelia burgdorferi OspB, MBP-tag. |
| REC31666-100 | Borrelia burgdorferi sensu stricto (B31) P35 Protein | Recombinant Borrelia burgdorferi P35, MBP-tag. |
| REC31667-100 | Borrelia burgdorferi sensu stricto (B31) P39 Protein | Recombinant Borrelia burgdorferi P39, MBP-tag. |
| NAT41595-100 | Feline Calicivirus Antigen | Feline Calicivirus produced in FC 3TG cells. |
| REC31670-100 | Puumala Virus Glycoprotein 2 (Gc), Human Fc-tag | Recombinant Puumala virus, glycoprotein 2 (aa 646-1116). Protein contains a human Fc-tag. |
| REC31670-500 | Puumala Virus Glycoprotein 2 (Gc), Human Fc-tag | Recombinant Puumala virus, glycoprotein 2 (aa 646-1116). Protein contains a human Fc-tag. |
| REC31673-100 | Borrelia burgdorferi sensu stricto (B31) ErpD/Arp37 Protein | Recombinant Borrelia burgdorferi Erpd/Arp37, MBP-tag. |
| REC31676-100 | Human Neuropilin-2 (NRP-2), His-tag | Recombinant human neuropilin-2 (amino acids 23-864), expressed in human embryonic kidney (HEK) 293 cells and purified from culture supernatant. The cytoplasmic tail and the transmembrane region were replaced by a 9 amino acid glycine-serine linker follow |
| REC31645-500 | Respiratory Syncytial Virus A Glycoprotein G, Mouse Fc-tag | Recombinant Respiratoy Syncytial virus (RSV), glycoprotein G (gG). Protein contains a mouse Fc-tag. |
| REC31654-250 | Severe Fever with Thrombocytopenia Syndrome Virus Nucleoprotein | Recombinant Severe Fever with Thrombocytopenia Virus Nucleoprotein produced in HEK293 cells, with an N-terminal His-tag. |
